
Find Journal
- 51 installs
- 236 repo stars
- Updated August 3, 2026
- aperivue/medsci-skills
Find-journal is a Claude Code skill that recommends the top-5 target journals for a medical manuscript by matching its abstract and study type against a curated journal-profile library.
About
Find-journal is a journal recommendation engine for medical manuscripts. Given an abstract, key findings, and study type, a researcher uses it to match against a curated public profile library plus optional private profiles and get the top 5 ranked journals with scope-fit rationale and AI-disclosure policy. It carries no cached impact-factor or APC data; users verify current metrics at journal sites.
- Journal recommendation engine matching a manuscript against a curated profile library
- 2-pass matching: compact profiles then top-5 enrichment with detailed write-paper profiles
- Weighted scoring (scope 40%, study-type 25%, tier 20%, OA 10%, special 5%) with AI-disclosure notes
Find Journal by the numbers
- 51 all-time installs (skills.sh)
- Ranked #804 of 1,879 Documentation skills by installs in the Skillselion catalog
- Data as of Aug 5, 2026 (Skillselion catalog sync)
find-journal capabilities & compatibility
- Capabilities
- fill icmje coi · fill protocol · humanize
- Use cases
- research · documentation
- Pricing
- Free
What find-journal says it does
Journal recommendation engine for medical manuscripts.
Returns ranked recommendations with scope fit rationale, AI disclosure policy, and homepage links.
No cached IF/APC data — users verify current metrics at journal sites.
npx skills add https://github.com/aperivue/medsci-skills --skill find-journalAdd your badge
Show developers this skill is listed on Skillselion. Paste this into your README.
| Installs | 51 |
|---|---|
| repo stars | ★ 236 |
| Last updated | August 3, 2026 |
| Repository | aperivue/medsci-skills ↗ |
What it does
Recommend the top-5 target journals for a medical manuscript by matching abstract and study type to journal profiles.
Who is it for?
Medical researchers deciding where to submit, who want ranked journals with scope-fit rationale and AI-policy notes.
Skip if: Providing current impact-factor or APC figures, which it deliberately does not cache.
When should I use this skill?
A manuscript is drafted and the author needs to choose a target journal to submit to.
What you get
Top-5 ranked journal recommendations with scope-fit rationale, AI-disclosure policy, and homepage links.
- top-5 ranked journal recommendations with rationale and links
By the numbers
- returns top 5 ranked recommendations
- 2-pass matching
- scope alignment weighted 40%
Files
Find Journal Skill
You are a journal recommendation engine for medical researchers. Given a manuscript's abstract, key findings, and study type, you match it against the curated public profile library plus any user-local private profiles, and return the top 5 ranked recommendations with scope fit rationale. Detailed write-paper profiles enrich the top-5 output when available.
Communication Rules
- Communicate with the user in their preferred language.
- Journal names, scope descriptions, and URLs are always in English.
- Medical terminology is always in English.
Key Directories
Compact profiles for matching (two-tier discovery)
1. Public library (shipped with the skill, curated + verified): ${CLAUDE_SKILL_DIR}/references/journal_profiles/ 2. User-local private library (per-user, never pushed to git, optional): $HOME/.claude/private-journal-profiles/find-journal/
The skill reads both directories and merges the results. Filenames must be unique across the two locations; on collision the private file wins (user override).
Detail profiles for top-5 enrichment (two-tier discovery)
1. Public: ${CLAUDE_SKILL_DIR}/../write-paper/references/journal_profiles/ 2. User-local private: $HOME/.claude/private-journal-profiles/write-paper/
Same merge rule — private wins on filename collision.
Why two tiers?
Profiles in the public library must meet a hard verification bar (direct source reading of the journal's homepage and author guidelines — no inference from adjacent journals, no family-policy copy-paste). Profiles that a single user wants for their own workflow but that have not cleared the public bar live in the private library. See ${CLAUDE_SKILL_DIR}/POLICY.md for the promotion checklist (private → public).
---
Phase 1: Input Collection
Required Inputs
1. Abstract text or key findings summary 2. Study type: original research, meta-analysis, case report, technical note, review, letter, AI validation, diagnostic accuracy, etc.
Optional Inputs
3. Preferred tier: Q1 / Q1-Q2 / any (default: any) 4. OA preference: Full OA / Hybrid OK / No preference (default: no preference) 5. Field focus: radiology, medical AI, clinical specialty, methodology, education, general medicine 6. Journals to exclude: list any journals that have previously rejected this manuscript
If the user provides only an abstract, extract the study type from context. If ambiguous, ask.
---
Phase 2: Theme Extraction
From the abstract/key findings, extract:
1. Disease/condition: e.g., hepatocellular carcinoma, pulmonary embolism, scoliosis 2. Modality/technique: e.g., CT, MRI, ultrasound, deep learning, meta-analysis 3. Methodology: e.g., retrospective cohort, diagnostic accuracy, systematic review, RCT 4. Population: e.g., pediatric, adult, screening population, surgical patients 5. Innovation type: e.g., new algorithm, clinical validation, workflow improvement, educational tool
---
Phase 3: Profile Loading and Matching (2-Pass)
3.1 Pass 1: Load Compact Profiles
Read journal profiles from both tiers:
# Public (shipped with the skill)
${CLAUDE_SKILL_DIR}/references/journal_profiles/*.md
# User-local private (optional, may be empty or absent)
$HOME/.claude/private-journal-profiles/find-journal/*.mdMerge into a single profile set. If a filename exists in both locations, the private copy takes precedence (user override). If the private directory does not exist, proceed with public-only — do not fail.
These are compact profiles (~30 lines each) optimized for matching. Parse each profile's Scope, Scope Keywords, Article Types Accepted, Classification (Tier, OA, Field), and Special Notes (includes 1-line AI policy summary).
Do NOT read write-paper profiles during this phase — they are 4-5x larger and contain formatting details irrelevant to journal matching.
3.2 Scoring Algorithm
For each journal, compute a composite score:
| Factor | Weight | Description |
|---|---|---|
| Scope alignment | 40% | How well the manuscript's themes match the journal's scope and keywords |
| Study type fit | 25% | Whether the journal accepts this article type and values this methodology |
| Tier match | 20% | Alignment with user's preferred tier (if specified) |
| OA match | 10% | Alignment with user's OA preference (if specified) |
| Special fit | 5% | Bonus for unique alignment with journal's Special Notes |
3.3 Filtering
Before scoring, exclude:
- Journals in the user's exclusion list
- Journals that do not accept the manuscript's study type (e.g., case report to a journal that only takes original research)
- If case report mode: only keep journals whose Article Types include case reports
3.4 Ranking
Sort by composite score. Select top 5.
3.5 Pass 2: Enrich Top-5
For each of the top-5 ranked journals, check both tiers for a detailed write-paper profile:
# Public
${CLAUDE_SKILL_DIR}/../write-paper/references/journal_profiles/{journal_filename}
# User-local private
$HOME/.claude/private-journal-profiles/write-paper/{journal_filename}Private takes precedence on collision. If found, read it to extract additional detail for the output:
- Manuscript types and word limits
- Abstract format and requirements
- Statistical reporting requirements
- AI Writing Disclosure Policy (full 5-field version)
- Common rejection reasons
This enriches the recommendation output without loading all write-paper profiles. If no write-paper profile exists, use the compact profile data only.
3.6 Profile Coverage Advisory
Before emitting the final output, scan the skill directory for profile-gap TODO files and decide whether to append a Coverage Advisory block.
What this step protects against. The recommendation list is bounded by what the public and private libraries contain. If a high-value journal is simply missing from both tiers, the ranking silently substitutes an adjacent journal and the user never learns that a better-fitting target exists. The Coverage Advisory surfaces known gaps and directs the user to /add-journal (or manual PDF + verification) to close them.
Procedure.
1. Locate TODO files. Glob ${CLAUDE_SKILL_DIR}/TODO_*_profiles.md. These are maintainer-curated gap files, one per field (e.g., TODO_neurointervention_profiles.md, future: TODO_pediatric_*, TODO_endocrinology_*). The file must contain a ## Field Keywords section — files without this section are ignored.
2. Match against manuscript themes. For each TODO file, read the Field Keywords block. If any keyword (case-insensitive, word-boundary match) appears in the manuscript's abstract or in the themes extracted in Phase 2, mark the TODO as relevant.
3. Parse the gap list. From each relevant TODO, extract the journal entries under headings matching ## 추가 필요 / ## Missing / ## Pending — they are the still-missing journals. Exclude any entry already marked completed (lines containing ✅ or "추가 완료 / Completed"). Also skip journals listed under ## Private (waiting on private→public promotion).
4. Emit the advisory. If at least one TODO is relevant and at least one journal in it is still missing, append a Coverage Advisory block immediately below the top-5 recommendation list and above the Mandatory Disclaimer. If no TODO is relevant, skip this block entirely — no false alarms.
Output format (when emitted).
---
### ⚠️ Profile Coverage Advisory — {field name}
Your manuscript matches keywords for the **{field name}** field, and the public profile
library has known gaps here. The following journals may be strong-fit candidates that did
not appear in the top-5 only because they are not yet in the library:
- **{Journal 1}** ({Publisher}) — {1-line reason from TODO entry}
- **{Journal 2}** ({Publisher}) — {1-line reason from TODO entry}
- ...
To add any of them to the public library:
1. Open the journal's author-guidelines page and save it as PDF (or paste the text).
2. Invoke `/add-journal` with the PDF — it transcribes the Identity / Scope / Article
Types / AI policy fields directly from the source and verifies the ISSN against
`portal.issn.org`, per `skills/find-journal/POLICY.md`.
3. After the new profile lands in `references/journal_profiles/`, re-run `/find-journal`
to see the updated ranking.
TODO source: `skills/find-journal/{TODO filename}`
---Guardrails.
- Do not fabricate journals, publishers, or rationale. Copy the TODO entry verbatim (or
paraphrase minimally from the same line).
- Do not promote a still-private profile into the advisory — private profiles are by
definition not production-ready.
- Keep the advisory concise (≤10 missing journals per field). If a TODO file lists more,
show the first 10 in priority order and add a "... and {N} more in the TODO file" line.
- The advisory is informational. It does not change the top-5 ranking or its scores.
---
Phase 4: Output
For each of the top 5 recommended journals, present:
### Rank [N]: [Journal Name] ([Tier])
**Scope fit:** [2-3 sentences explaining why this manuscript matches this journal's scope.
Reference specific keywords, disease areas, or methodological preferences from the profile.]
**Article types accepted:** [relevant types from profile]
**Open Access:** [Full OA / Hybrid / Subscription]
**Homepage:** [URL]
**Author guidelines:** [URL]
**AI disclosure:** [Required / Recommended / Not specified] — [brief summary of permitted scope and disclosure location, if available in profile]After all 5 recommendations, add a brief comparison note (2-3 sentences) highlighting the key tradeoffs between the top choices (e.g., scope breadth vs. specialty depth, tier vs. acceptance likelihood).
If Phase 3.6 produced a Coverage Advisory, insert it immediately after the comparison note and before the Mandatory Disclaimer.
---
Mandatory Disclaimer
Always append this disclaimer at the bottom of every recommendation output:
---
**Important Disclaimer**
Impact Factor, APC fees, acceptance rates, and turnaround times change frequently
and are subject to copyright restrictions. Please verify current values directly
at each journal's homepage before making your submission decision.
Recommended verification sources:
- Journal Citation Reports (JCR) via institutional access: for Impact Factor
- Journal homepage -> Author Guidelines: for current APC and formatting requirements
- Clarivate Master Journal List: for indexing status---
Special Modes
Post-Rejection Mode
When the user indicates a manuscript was rejected from a specific journal:
1. Exclude the rejecting journal from recommendations 2. Prioritize journals at the same tier or one tier lower than the rejecting journal 3. If rejected from Q1, recommend mix of Q1 (different scope angle) and strong Q2 4. In the scope fit explanation, note how the recommendation differs from the rejected journal's focus 5. Suggest any scope adjustments that might improve fit for the new target
Case Report Mode
When study type is "case report":
1. Filter the compact profiles to only journals whose Article Types include case reports 2. Prioritize journals known for valuing educational or rare cases 3. If fewer than 5 journals accept case reports, note this and suggest the user consider case-report-specific journals outside the profile set
Cross-Skill Integration
This skill feeds into other skills in the pipeline:
- write-paper Phase 8+: Once a target journal is selected, the write-paper skill
uses the journal profile for cover letter drafting and formatting
- self-review: The selected journal's scope and requirements inform the self-review
checklist priorities
- check-reporting: The journal's preferred reporting guidelines are passed to
check-reporting for compliance verification
When called from write-paper or another skill, accept the abstract and study type from the calling context and skip redundant input collection.
Submission Directory Scaffolding
When the user selects a target journal from the recommendations, create the submission/{journal_short}/ directory structure:
submission/
└── {journal_short}/ # e.g., radiology_ai/
├── cover_letter.md # Generated by /write-paper Phase 8+
├── checklist.md # Journal-specific submission checklist
└── peer_review.md # Generated by /peer-review (journal scope-aware)The {journal_short} name uses lowercase with underscores (e.g., radiology_ai, european_radiology, ajr). Create the directory and report the path to the user so subsequent skills (/write-paper Phase 8+, /peer-review) know where to write.
---
Error Handling
- Count the compact profiles actually found (public + private after merge) at runtime and note the total in the output — never hard-code the count
- If either tier directory is missing or empty, proceed with the other tier and note which tier was unavailable
- If the write-paper profiles directory is not accessible for Pass 2 enrichment, output recommendations using compact profile data only
- If no journals match after filtering, relax filters (remove OA constraint first, then tier) and re-score
- Never fabricate journal information not present in the profiles
Anti-Hallucination
- Never fabricate file paths, URLs, DOIs, or package names. Verify existence before recommending.
- Never invent journal metadata, impact factors, or submission policies without verification at the journal's website.
- If a tool, package, or resource does not exist or you are unsure, say so explicitly rather than guessing.
Journal Profile Policy
This document defines what a profile must satisfy to live in the public profile library (skills/find-journal/references/journal_profiles/ and the matching write-paper directory) versus the user-local private library ($HOME/.claude/private-journal-profiles/).
Why two tiers
The public library ships with the skill and is consumed by every user. A profile that misrepresents a journal's author guidelines — wrong ISSN, wrong article types, wrong AI policy wording — propagates that error to every downstream researcher. The private tier exists so a single user can keep working notes and personal-use profiles without polluting the shared library.
The verification bar (public library)
Every public profile must meet all of the following. No exceptions, no defaults.
Source discipline
1. The journal's homepage was opened directly (not inferred from a sibling journal). 2. The journal's Author Guidelines page was opened directly, or equivalent authoritative sections were pasted into the session by the maintainer. 3. Every line of the profile cites or is traceable to content on (1) or (2). Plausible inference from adjacent journals is not acceptable, even when the journals are in the same publisher family.
Field-level checks
Publisher— transcribed from the journal's own masthead / about page.ISSN (print/online)— transcribed from the journal's own masthead or ISSN Portal
(portal.issn.org) entry for that exact journal.
HomepageandAuthor guidelinesURLs — both return 200 OK when the profile is
written. If the guidelines page is 403/login-gated, either paste the accessible sections or defer to the private tier.
Article Types Accepted— listed in the journal's own submission/instructions page.
No "typical for this publisher family" article types.
AI policysentence — transcribed from the journal's or publisher's AI policy page.
Family-level defaults (e.g., "follows AHA policy aligned with ICMJE") are only acceptable if the journal's own page links to or repeats that family policy; they are not a substitute for checking.
Special Notes— any "Choose X over Y" decision rule must be defensible from what the
two journals' own scope statements say, not from general reputation.
Proof of verification
Profile authors or maintainers should keep a brief evidence note — either a 1-line comment at the bottom of the profile, a PR description, or a commit message — stating which pages were opened and on what date. This lets future audits check whether a profile has drifted.
Single entry point for profile creation
Profiles are added and edited through the /add-journal skill. Ad-hoc profile creation (spawning a research agent, writing freehand, copying from another profile) is not permitted for the public library because it bypasses the skill's built-in 403 handling, TODO-marking, and anti-hallucination rules.
For one-off personal profiles a user is welcome to write freehand into the private tier, but the same source-discipline principles apply — infer less, verify more.
Promotion checklist (private → public)
Before moving a profile from your local private profiles directory (outside this repo) into skills/*/references/journal_profiles/, confirm each item:
- [ ] Journal homepage fetched successfully today and opened manually.
- [ ] Author guidelines page fetched successfully today and opened manually.
- [ ] ISSN cross-checked against portal.issn.org entry for the exact journal name.
- [ ] Publisher name transcribed from the journal's masthead, not inferred.
- [ ] Article types list present on the journal's own page — no family inference.
- [ ] AI policy sentence transcribed from the journal's or publisher's policy page — no
sibling-journal copy-paste.
- [ ] "Choose X over Y" decision rule defensible from each journal's own scope text.
- [ ] No
[TODO: verify at journal site]markers remaining. - [ ] Commit message records which pages were opened and on what date.
Only after all items pass does git mv from private to public become appropriate.
Demotion (public → private)
If an existing public profile is found to fail this bar, either:
1. Fix it in place and commit the correction with evidence, or 2. Demote it back to the private tier with git mv and a commit message recording why.
Silently leaving a questionable profile in the public library is not an option.
Abdominal Radiology
Identity
- Abbreviation: Abdom Radiol
- Publisher: Springer Nature (Society of Abdominal Radiology)
- ISSN: 2366-004X / 2366-0058
- Homepage: https://www.springer.com/journal/261
- Author guidelines: https://www.springer.com/journal/261/submission-guidelines
Scope
Abdominal Radiology publishes original research, reviews, and case studies focused on imaging of the abdomen and pelvis, including the gastrointestinal tract, liver, pancreas, biliary system, kidneys, adrenal glands, and genitourinary system. All imaging modalities are covered, with emphasis on CT, MRI, and ultrasound of abdominal organs.
Scope Keywords
abdominal imaging, liver imaging, pancreas imaging, renal imaging, gastrointestinal imaging, CT abdomen, MRI abdomen, hepatocellular carcinoma, colorectal cancer, kidney tumor, adrenal imaging, biliary imaging, pelvic imaging, genitourinary imaging, contrast-enhanced ultrasound
Article Types Accepted
- Original Article
- Review Article
- Pictorial Essay
- Case Report (as Brief Report)
- Technical Innovation
- Letter to the Editor
Classification
- Tier: Q2
- Open Access: Hybrid (Springer transformative agreements)
- Field: Radiology / Abdominal imaging
Special Notes
Abdominal Radiology is the official journal of the Society of Abdominal Radiology (SAR). It was formed by the merger of the abdominal imaging sections of Journal of Computer Assisted Tomography and the former Abdominal Imaging journal. The journal regularly publishes themed issues and disease-focused supplements. It is a strong home for LI-RADS, PI-RADS, and other structured reporting studies.
Academic Radiology
Identity
- Abbreviation: Acad Radiol
- Publisher: Elsevier (Association of Academic Radiology)
- ISSN: 1076-6332 / 1878-4046
- Homepage: https://www.academicradiology.org/
- Author guidelines: https://www.elsevier.com/journals/academic-radiology/1076-6332/guide-for-authors
Scope
Academic Radiology publishes original investigations, clinical reviews, and innovations in radiology education, health services research, imaging informatics, and quality improvement, with emphasis on the academic mission of radiology departments.
Scope Keywords
radiology education, health services research, imaging informatics, quality improvement, AI in radiology, medical imaging, radiology training, diagnostic accuracy, imaging policy, radiology workforce, machine learning, patient safety, clinical decision support, imaging utilization, evidence-based radiology
Article Types Accepted
- Original Investigation
- Clinical Review / Systematic Review
- Innovations
- Perspectives
- White Papers
- Letter to the Editor
Classification
- Tier: Q1
- Open Access: Hybrid
- Field: Radiology / Education / Health services
Special Notes
Academic Radiology is the official journal of the Association of University Radiologists (AUR) and the Alliance of Medical Student Educators in Radiology (AMSER). It uniquely bridges clinical radiology research with education, informatics, and practice management. Double-blind review process with mandatory AI declaration. AI policy: language editing only, Methods disclosure required per ICMJE.
American Journal of Neuroradiology
Identity
- Abbreviation: AJNR Am J Neuroradiol
- Publisher: American Society of Neuroradiology (ASNR)
- ISSN: 0195-6108 / 1936-959X
- Homepage: https://www.ajnr.org/
- Author guidelines: https://www.ajnr.org/page/authors
Scope
AJNR publishes original research, reviews, and technical innovations in diagnostic and interventional neuroradiology, covering brain, spine, and head/neck imaging across all modalities including advanced MRI techniques, functional imaging, and AI applications in neuroradiology.
Scope Keywords
neuroradiology, brain imaging, spine imaging, head and neck imaging, cerebrovascular disease, stroke imaging, brain tumor, glioma, MR spectroscopy, diffusion tensor imaging, functional MRI, pediatric neuroimaging, neurodegenerative disease, white matter disease, AI neuroradiology, perfusion imaging
Article Types Accepted
- Original Research
- Review Article
- Technical Note
- Case Report
- Letter to the Editor
Classification
- Tier: Q1
- Open Access: Hybrid
- Field: Neuroradiology
Special Notes
AJNR is the flagship journal of the American Society of Neuroradiology and covers both diagnostic and interventional neuroradiology (though purely interventional papers may fit INSI better). Requires a unique "What This Adds to the Published Literature" box with 3 bullet points. AI policy: follows ICMJE — disclose AI use in Methods.
American Journal of Roentgenology
Identity
- Abbreviation: AJR Am J Roentgenol
- Publisher: American Roentgen Ray Society (ARRS)
- ISSN: 0361-803X / 1546-3141
- Homepage: https://www.ajronline.org/
- Author guidelines: https://www.ajronline.org/page/authors
Scope
AJR publishes original research, reviews, and technical innovations across all subspecialties of diagnostic radiology, with strong emphasis on clinical imaging practice, diagnostic accuracy studies, and AI applications in medical imaging.
Scope Keywords
diagnostic radiology, body imaging, CT, MRI, ultrasound, abdominal imaging, thoracic imaging, musculoskeletal imaging, breast imaging, genitourinary imaging, pediatric radiology, AI in radiology, diagnostic accuracy, imaging biomarkers, contrast media, interventional radiology
Article Types Accepted
- Original Research
- Brief Report
- Review Article
- Pictorial Essay
- Technical Innovation
- Letter to the Editor
Classification
- Tier: Q1
- Open Access: Hybrid
- Field: Radiology (general)
Special Notes
AJR is one of the oldest and most widely read general radiology journals, published by ARRS since 1906. It requires both a "What Does This Article Add?" box and "Key Points" for original research. Strong emphasis on clinical relevance and practical applicability of findings. AI policy: follows ICMJE — disclose AI use in Methods.
Annals of Internal Medicine
Identity
- Abbreviation: Ann Intern Med
- Publisher: American College of Physicians (ACP)
- ISSN: 0003-4819 / 1539-3704
- Homepage: https://www.acpjournals.org/journal/aim
- Author guidelines: https://www.acpjournals.org/journal/aim/authors
Scope
Annals of Internal Medicine publishes original research, systematic reviews, clinical guidelines, and essays relevant to internal medicine and its subspecialties. It values rigorous methodology, clinical relevance, and findings that directly inform patient care. Known for publishing the TRIPOD and STARD statements, the journal has strong standards for diagnostic accuracy and prediction model reporting.
Scope Keywords
internal medicine, clinical outcomes, diagnostic accuracy, prediction models, systematic review, evidence-based medicine, screening, therapeutics, prevention, health services research, quality improvement, clinical guidelines, patient safety, epidemiology, biostatistics
Article Types Accepted
- Original Research
- Systematic Review
- Research Letter
- Review
- Ideas and Opinions
- Clinical Guidelines
- In the Clinic
- Beyond the Guidelines
- On Being a Doctor (narrative)
Classification
- Tier: Q1
- Open Access: Hybrid (optional OA)
- Field: General / internal medicine
Special Notes
Annals is the only major general medical journal to require a "Limitation" heading in the structured abstract. It enforces double-blind peer review with dedicated statistical reviewers. Known for rigorous TRIPOD compliance in prediction model papers. If rejected, authors can request transfer to ACP's Annals of Family Medicine. Visual abstracts are encouraged for social media visibility. The journal also publishes "Summaries for Patients" companion pieces for all original research.
Artificial Intelligence in Medicine
Identity
- Abbreviation: Artif Intell Med
- Publisher: Elsevier
- ISSN: 0933-3657 / 1873-2860
- Homepage: https://www.sciencedirect.com/journal/artificial-intelligence-in-medicine
- Author guidelines: https://www.elsevier.com/journals/artificial-intelligence-in-medicine/0933-3657/guide-for-authors
Scope
Publishes original research on AI techniques applied to medicine, emphasizing methodological novelty beyond mere application of known algorithms to medical data. Covers knowledge-based systems, machine learning, NLP, and decision support with demonstrated clinical relevance.
Scope Keywords
artificial intelligence, machine learning, clinical decision support, natural language processing, knowledge representation, medical informatics, deep learning, explainable AI, predictive modeling, electronic health records, computer-aided diagnosis, clinical NLP, Bayesian networks, reinforcement learning, medical reasoning
Article Types Accepted
- Original Research
- Methodological Review/Survey
- Position Paper
- Letter to the Editor
Classification
- Tier: Q1
- Open Access: Hybrid
- Field: Medical AI / Health informatics
Special Notes
Premier AI-in-medicine journal requiring genuine methodological novelty — not just applying existing algorithms to medical data. Clinical assessment strongly recommended. Single-blind review; median first decision ~12 days. AI policy: AI-generated images not permitted in artwork; follows ICMJE for AI text disclosure.
BJR Case Reports
Identity
- Abbreviation: BJR Case Rep
- Publisher: British Institute of Radiology (BIR), published by Oxford University Press
- ISSN: 2055-7159 (electronic)
- Homepage: https://academic.oup.com/bjrcr
- Author guidelines: https://academic.oup.com/bjrcr/pages/general-instructions
Scope
The case-report companion to the British Journal of Radiology, dedicated to imaging-led case reports across all radiology subspecialties and modalities (radiography, ultrasound, CT, MRI, nuclear medicine/PET, and interventional radiology). Strong fit for instructive imaging findings, rare presentations, diagnostic pitfalls/mimics, and image-guided procedures or complications.
Scope Keywords
radiology case report, imaging findings, diagnostic pitfall, multimodality imaging, interventional radiology, nuclear medicine, PET/CT, rare imaging presentation, structured reporting, image-guided procedure
Article Types Accepted
- Case Report
- Case Series
- (imaging-focused) Pictorial / instructive case
Classification
- Tier: Q3/Q4 (radiology case-report-dedicated)
- Open Access: Full gold OA, CC BY 4.0 (APC applies — verify current amount)
- Field: Radiology / medical imaging
Special Notes
Radiology-society home for the imaging case that a general case-report journal cannot showcase. Expects high-quality, de-identified, annotated image panels, explicit per-modality technique→findings→ impression description, and use of structured-reporting categories where applicable. Patient consent for publication of images is required. Pairs with write-paper exemplar_case_report_radiology.md and make-figures exemplar_plots/imaging_panel.md.
Verification
Identity (BIR/Oxford, ISSN 2055-7159, CC-BY, imaging case-report scope) verified 2026-06-15 against a current CC-BY article in the journal (Europe PMC). Specific word/figure/reference limits and the current APC were not independently fetched — confirm at the author-guidelines URL before submission.
BMC Medicine
Identity
- Abbreviation: BMC Med
- Publisher: BioMed Central (Springer Nature)
- ISSN: 1741-7015
- Homepage: https://bmcmedicine.biomedcentral.com/
- Author guidelines: https://bmcmedicine.biomedcentral.com/submission-guidelines
Scope
BMC Medicine is a broadly scoped, open access journal that publishes outstanding and influential research in all areas of clinical practice, translational medicine, medical and health science, and global health. It prioritizes studies that advance clinical understanding, inform health policy, or provide important evidence synthesis relevant to a wide medical audience.
Scope Keywords
clinical research, translational medicine, global health, epidemiology, public health, systematic review, meta-analysis, clinical trials, health policy, evidence synthesis, precision medicine, infectious disease, chronic disease, health services, diagnostic accuracy
Article Types Accepted
- Research Article
- Systematic Review and Meta-Analysis
- Research in Context (commissioned)
- Opinion
- Commentary
- Correspondence
- Study Protocol
Classification
- Tier: Q1
- Open Access: Full OA (APC ~$3,690)
- Field: General medicine
Special Notes
BMC Medicine is one of the leading fully OA general medicine journals (IF ~7-9). Fast peer review (~30 days first decision). Registered reports supported. Strong in systematic reviews and multi-site clinical studies. EQUATOR network reporting guidelines strictly enforced. Accepts transfers from other BMC journals. AI policy: follows ICMJE — disclose AI use in Methods.
BMJ Case Reports
Identity
- Abbreviation: BMJ Case Rep
- Publisher: BMJ Publishing Group
- ISSN: 1757-790X (electronic)
- Homepage: https://casereports.bmj.com/
- Author guidelines: https://casereports.bmj.com/pages/authors/
Scope
One of the largest dedicated case-report repositories, covering case reports across all clinical specialties, with structured article types aimed at clinical learning. Strong emphasis on educational value, patient consent, and global relevance.
Scope Keywords
case report, clinical learning, rare disease, novel diagnostic/therapeutic, reminder of important clinical lesson, images in medicine, global health, all specialties
Article Types Accepted
- Case Report
- Images In… (image-led short report)
- Case Reports of "Reminder of important clinical lesson", "Novel diagnostic/therapeutic technique", "Unusual presentation of more common disease/injury", "Rare disease", "Findings that shed new light on the possible pathogenesis", "Unexpected outcome", "Learning from errors"
- Global Health case reports
Classification
- Tier: Q3 (case-report-dedicated, high volume)
- Open Access: Fellowship-membership model (institutional or individual annual fellowship grants submission/publication rights) rather than a per-article APC
- Field: General clinical medicine / case reports (all specialties)
Special Notes
Patient consent is mandatory on the journal's own BMJ consent form (not just a generic statement) — this is the most common reason submissions stall. Article-type taxonomy is explicit; choose the category that matches the teaching point. Membership model can be cost-free to authors at subscribing institutions.
Verification
Scope, article-type taxonomy, ISSN, and the fellowship-membership/consent-form model reflect BMJ Case Reports' long-standing public model (well-established convention). The author-guidelines page returned 403 to automated fetch on 2026-06-15 and was not independently parsed — confirm the current consent-form requirement, fellowship terms, and per-type word limits at the guidelines URL before submission.
British Journal of Radiology
Identity
- Abbreviation: BJR
- Publisher: Oxford University Press (British Institute of Radiology)
- ISSN: 0007-1285 / 1748-880X
- Homepage: https://academic.oup.com/bjr
- Author guidelines: https://academic.oup.com/bjr/pages/author-guidelines
Scope
BJR publishes original research, reviews, and pictorial reviews across all subspecialties of diagnostic radiology, interventional radiology, nuclear medicine, radiation oncology, and radiation physics, with emphasis on clinical research, methodology, and translational radiology and an explicit "Advances in knowledge" novelty framing.
Scope Keywords
diagnostic radiology, interventional radiology, nuclear medicine, radiation oncology, radiation physics, CT, MRI, ultrasound, PET, clinical radiology, translational imaging, advances in knowledge, methodology, multi-center radiology
Article Types Accepted
- Research Article
- Review
- Systematic Review
- Pictorial Review
- Guidelines
- Short Communication
- Commentary
- Letter to the Editor
Classification
- Tier: Q2 (general radiology; verify current JCR rank)
- Open Access: Hybrid (optional CC BY / CC BY-NC; APC ~£2,393)
- Field: Radiology (general; includes physics + radiation oncology)
Special Notes
British Institute of Radiology flagship; UK/European general-radiology readership; double-anonymized peer review (blind all upload files except title page); structured abstract requires the BJR-specific "Advances in knowledge" heading. AI policy: mandatory disclosure in both cover letter AND Methods/Acknowledgements; AI tools cannot be listed as authors; AI image generation must be disclosed.
---
Verification
- Source: https://academic.oup.com/bjr/pages/author-guidelines
- Date: 2026-05-21
CHEST
Identity
- Abbreviation: Chest
- Publisher: Elsevier on behalf of the American College of Chest Physicians (ACCP)
- ISSN: 0012-3692 / 1931-3543
- Homepage: https://journal.chestnet.org/
- Author guidelines: https://journal.chestnet.org/content/authors
Scope
CHEST publishes clinical research, reviews, and evidence-based guidelines in pulmonary medicine, critical care, and sleep medicine, emphasizing work with direct practice impact. Coverage spans COPD, asthma, lung cancer and nodule management, interstitial lung disease, pulmonary hypertension, venous thromboembolism, mechanical ventilation and sepsis/ARDS, sleep-disordered breathing, bronchoscopy, and chest imaging (including Lung-RADS and Fleischner-guideline research).
Scope Keywords
pulmonary medicine, COPD, emphysema, asthma, lung cancer, lung nodule, Lung-RADS, interstitial lung disease, pulmonary fibrosis, pulmonary embolism, critical care, mechanical ventilation, ARDS, sepsis, sleep apnea, pulmonary hypertension, chest imaging, bronchoscopy, smoking cessation
Article Types Accepted
- Original Research (unsolicited; 300-word structured abstract; 3,200 words; 50 refs)
- Research Letter (1,000 words; 10 refs)
- Systematic Review (without MA; 3,200 words; 75 refs)
- Scoping Review (3,200 words; 50 refs)
- Guidelines and Consensus Statements (4,000 words; 150 refs)
- Narrative Review (invited; 3,500 words; 75 refs)
- Special Feature (invited; 3,500 words; 75 refs)
- How I Do It (invited; 3,000 words; 50 refs)
- Point/Counterpoint + Dilemma Debate (invited)
- Editorials / CHEST Commentary (invited)
- Case sections (online only): Novel Reports, Chest Imaging & Pathology for Clinicians, CHEST Pearls, Ultrasound Corner
- Humanities in CHEST Medicine (Case-Based Discussion, Consilia Historiae, Vantage, Exhalations, Original Research)
- Letter to the Editor / Response (400 words; 5 refs)
Classification
- Tier: Q1
- Open Access: Hybrid (APC $4,160; CC BY-NC-ND default, CC BY for mandated funders)
- Field: Pulmonary medicine / Critical care / Sleep medicine
Special Notes
Flagship journal of the American College of Chest Physicians (ACCP). Double-anonymized peer review via Editorial Manager — submission requires separate uploads for cover letter, title page (author details), and a fully anonymized manuscript. CHEST uses distinctive terminology: "Research Question" (not Objective), "Study Design and Methods" (not Methods), and "Interpretation" (not Conclusion) in both the 6-section structured abstract and main-text section headings. A Take-Home Point pullout (3 short sentences) is required at submission. Lung imaging studies (CT screening, nodule detection AI, COPD/emphysema quantification) are well within scope when linked to clinical endpoints. Tobacco-industry-funded research is not accepted. Systematic reviews with meta-analysis are submitted as Original Research, not as Systematic Reviews. AI policy: generative AI disclosure required when used for readability/language — add a "Declaration of Generative AI and AI-assisted technologies in the writing process" section before the References list; AI tools cannot be authors.
<!-- Source verification: Author guidelines pasted by maintainer 2026-04-20; ISSN/publisher confirmed against journal masthead. Promoted from private tier to public on 2026-04-20. -->
Clinical and Molecular Hepatology
Identity
- Abbreviation: Clin Mol Hepatol
- Publisher: Korean Association for the Study of the Liver (KASL)
- ISSN: 2287-2728 / 2287-285X
- Homepage: https://www.e-cmh.org
- Author guidelines: https://www.e-cmh.org/authors/authors.php
Scope
Clinical and Molecular Hepatology is the KASL flagship journal publishing original basic and clinical research on liver diseases. Particularly receptive to Korean and Asian cohort epidemiology, MASLD/NAFLD natural history, chronic hepatitis B/C management, HCC surveillance, and studies citing KASL practice guidelines.
Scope Keywords
hepatology, liver disease, MASLD, NAFLD, MetALD, ALD, chronic hepatitis B, chronic hepatitis C, hepatocellular carcinoma, HCC, cirrhosis, liver fibrosis, FIB-4, Korean cohort, Asian epidemiology, KASL guidelines, 2023 SLD nomenclature, lean MASLD, fatty liver, liver transplantation
Article Types Accepted
- Original Article
- Review Article (invited; unsolicited reviews accepted for peer review)
- Editorial (invited)
- Special Topic (guidelines, meeting reports, hepatology issues elsewhere)
- Letter to the Editor (online-only; within 2 years of cited article)
- Correspondence (online-only; reply to editorial)
- Research Letter (online-only; concise original study)
- Snapshot (graphical single-page summary)
Classification
- Tier: Q1 hepatology
- Open Access: Full OA (APC US$1,500 since 2024-02-05)
- Field: hepatology, observational cohort epidemiology, Korean/Asian clinical research
Special Notes
KASL flagship journal with strong preference for Korean screening-cohort epidemiology and 2023 SLD nomenclature applications. Original articles require a mandatory graphical abstract (531×531 px, 600 dpi) and structured abstract (Background/Aims, Methods, Results, Conclusions). Fast-track review available for US$1,000 with 7-day first decision. AI policy: follows ICMJE — disclose AI use in Acknowledgements with software name, version, manufacturer, dates, and description of use; AI cannot be author; citation of AI-generated material as primary source is prohibited.
Clinical Radiology
Identity
- Abbreviation: Clin Radiol
- Publisher: Elsevier (Royal College of Radiologists, RCR)
- ISSN: 0009-9260 / 1365-229X
- Homepage: https://www.clinicalradiologyonline.net/
- Author guidelines: https://www.clinicalradiologyonline.net/content/authorinfo
Scope
Clinical Radiology publishes original research, reviews, case reports, and pictorial reviews across all areas of diagnostic and interventional radiology. As the official journal of the Royal College of Radiologists, it emphasizes clinical practice, service improvement, and evidence-based radiology with particular relevance to UK and Commonwealth healthcare systems.
Scope Keywords
clinical radiology, diagnostic imaging, CT, MRI, ultrasound, interventional radiology, radiology practice, NHS radiology, audit, quality improvement, radiation dose, screening, radiology training, AI in radiology, radiological anatomy, pictorial review
Article Types Accepted
- Original Article
- Review Article
- Technical Note
- Case Report
- Pictorial Review
- Letter to the Editor
Classification
- Tier: Q2
- Open Access: Hybrid (Elsevier OA option)
- Field: Radiology / General
Special Notes
Clinical Radiology is the official journal of the Royal College of Radiologists (RCR). British English is mandatory throughout. The journal values studies with practical relevance to UK radiology practice, including NHS audit and quality improvement work. Pictorial reviews with educational value are a strength. For European multicenter studies, consider European Radiology; for higher-impact general radiology, consider Radiology or AJR.
Cureus
Identity
- Abbreviation: Cureus
- Publisher: Cureus, Inc. (Springer Nature)
- ISSN: 2168-8184 (electronic)
- Homepage: https://www.cureus.com/
- Author guidelines: https://www.cureus.com/author_guide
Scope
Multispecialty, online-only, open-access medical journal publishing research relevant to global healthcare, using a Continuous Article Publication model for rapid dissemination. Broadly receptive to case reports across specialties, including imaging, pharmacovigilance/adverse-event, and educational cases.
Scope Keywords
multispecialty, case report, technical report, original research, review, rapid publication, global health, medical education, adverse drug reaction, imaging
Article Types Accepted
- Original Article
- Review Article
- Case Report
- Technical Report
- Editorial
Classification
- Tier: Q3 (multispecialty, rapid)
- Open Access: Full OA, CC BY 4.0; no universal APC ("zero editing fee" when formatting/language requirements are met; optional paid Preferred Editing otherwise)
- Field: Multispecialty medicine
Special Notes
Requires at least two completed independent peer reviews; reviewers from the author's institution are excluded. Authors are asked to invite several advisers for non-peer feedback during submission. Fast turnaround and a low/zero-cost route make it a common home for student/trainee case reports — but the scientific bar (consent, de-identification, causality discipline) still applies.
Verification
Identity, article types, OA/CC-BY, no-universal-APC model, and the two-reviewer requirement verified 2026-06-15 against the public author guide and a current CC-BY article (Europe PMC). Specific case-report word/figure limits were not stated on the fetched page — confirm at the author guide before submission.
CardioVascular and Interventional Radiology
Identity
- Abbreviation: Cardiovasc Intervent Radiol
- Publisher: Springer Nature (CIRSE — Cardiovascular and Interventional Radiological Society of Europe)
- ISSN: 0174-1551 / 1432-086X
- Homepage: https://www.springer.com/journal/270
- Author guidelines: https://www.springer.com/journal/270/submission-guidelines
Scope
CVIR publishes original research, reviews, meta-analyses, and case reports on all aspects of cardiovascular and interventional radiology. Coverage includes vascular interventions, tumor ablation, embolization, drainage procedures, CBCT-guided interventions, and image-guided minimally invasive therapies. The journal emphasizes clinical outcomes, technical innovation, and evidence synthesis in IR practice.
Scope Keywords
interventional radiology, embolization, ablation, vascular intervention, CBCT, cone-beam CT, drainage, stenting, angioplasty, thrombolysis, TACE, radioembolization, image-guided therapy, percutaneous biopsy, venous access, portal vein embolization, IR outcomes
Article Types Accepted (CVIR taxonomy + limits)
- Clinical Investigation — 2400 words, structured 250-word abstract, 6 images
- Laboratory Investigation — 2400 words, structured 250, 6 images
- Scientific Paper (Other) — 2400 words, structured 250, 6 images — this is the type for META-ANALYSES
- Review Article — 3000 words, simple 125-word abstract, 10 images (includes narrative systematic reviews)
- Case Report — 1000 words, simple 125, 3 images, refs max 10
- Short Communication — 1200 words, structured 250, 3 images
- Study Protocol — 2400 words, structured 250, 3 images
- Letter to the Editor — 900 words, no abstract, 3 images, refs max 5
Classification
- Tier: Q2
- Open Access: Hybrid (Open Choice)
- Field: Radiology / Interventional radiology
- Peer review: Double-blind (anonymize the main manuscript)
Special Notes
CVIR is the official journal of CIRSE. It readily accepts meta-analyses of IR procedures, but a meta-analysis is the "Scientific Paper (Other)" type → 2400 words / 6 images, NOT a 3500–4000-word allowance (a frequent miscalibration). Double-blind review: the body must be fully anonymized; all author/funding/ethics info goes on a separate Title Page with the five "Compliance with Ethical Standards" statements. Abstract: structured 250 words, no abbreviations, with a Level of Evidence line. Complication reporting must use SIR classification or Clavien-Dindo. Technical success and technique efficacy must be explicitly defined. For North American-focused IR studies, consider JVIR. Detailed profile: write-paper/references/journal_profiles/CVIR.md.
Verification
- Source: CVIR Manuscript Type Manual (December 2025) + Springer Instructions for Authors.
- Last verified: 2026-06-14.
Diabetes & Metabolism Journal
Identity
- Abbreviation: Diabetes Metab J
- Publisher: Korean Diabetes Association (KDA)
- ISSN: [TODO: verify at e-dmj.org]
- Homepage: https://e-dmj.org
- Author guidelines: https://e-dmj.org/authors/authors.php
Scope
Diabetes & Metabolism Journal is the official English-language journal of the Korean Diabetes Association covering diabetes mellitus, metabolic disorders, and endocrinology — clinical, epidemiological, and basic-science research. The journal is particularly receptive to Korean and East Asian population studies addressing diabetes epidemiology, prevention, treatment, complications, body composition, metabolic syndrome, and related cohort outcomes.
Scope Keywords
diabetes mellitus, type 2 diabetes, metabolic syndrome, body composition, sarcopenia, sarcopenic obesity, hepatic steatosis, MASLD, insulin resistance, HOMA-IR, glycaemic control, prediabetes, Korean cohort, East Asian population, KDA, diabetes prevention, diabetes complications, endocrinology, lipid disorders
Article Types Accepted
- Original Article (4,000 words, abstract <250, refs ≤50, ≤6 figures/tables)
- Review Article (abstract <200, refs ≤150)
- Brief Report (1,500 words, abstract <180, refs ≤20, ≤2 figures)
- Editorial (refs ≤20)
- Letter to the Editor (1,000 words, refs ≤10, 1 figure or 1 table)
Classification
- Tier: Q2 (specialty diabetes/endocrinology journal)
- Open Access: Full OA, Creative Commons Attribution Non-Commercial License (CC BY-NC)
- Field: Diabetes / Endocrinology / Metabolic Disease
Special Notes
Diabetes & Metabolism Journal is the KDA flagship English-language journal, bimonthly (Jan/Mar/May/Jul/Sep/Nov). Double-blind peer review ensuring both authors and reviewers remain anonymous. Strict 4,000-word body limit for Original Article (excluding abstract, references, legends); structured abstract (Background-Methods-Results-Conclusion) ≤250 words; 3–10 MeSH keywords. Reporting guidelines mandated per study design (CONSORT/STROBE/PRISMA/CARE). Figure resolution ≥300 DPI in JPEG/EPS/TIFF/PICT format. AI policy: authors must disclose AI tool, version, manufacturer, and writing role on the title page; AI cannot be listed as author; AI-generated images prohibited. Particularly receptive to Korean and East Asian diabetes cohort studies and body-composition / metabolic-outcome research with single-institution observational designs.
---
Verification
- Source: https://e-dmj.org/authors/authors.php
- Date: 2026-05-21
Diagnostic and Interventional Radiology
Identity
- Abbreviation: Diagn Interv Radiol (DIR)
- Publisher: Galenos Publishing House (Turkish Society of Radiology)
- ISSN: 1305-3825 / 1305-3612
- Homepage: https://www.dirjournal.org/
- Author guidelines: https://www.dirjournal.org/ (Instructions to Authors)
Scope
Bimonthly, double-blind, fully open-access journal covering diagnostic and interventional radiology — original investigations, reviews, meta-analyses, pictorial essays, and technical notes across all radiology subspecialties. Indexed in SCIE, PubMed/MEDLINE, PMC, Scopus, EMBASE, DOAJ.
Scope Keywords
diagnostic radiology, interventional radiology, imaging, CT, MRI, ultrasound, PET, angiography, embolization, biopsy, ablation, image-guided therapy, radiology AI, diagnostic accuracy, meta-analysis, technical note, pictorial essay, Turkish radiology
Article Types Accepted
- Original Article (4500w, 400w structured abstract with PURPOSE/METHODS/RESULTS/CONCLUSION/CLINICAL SIGNIFICANCE)
- Review Article (4000w)
- Meta-Analysis (4000w, 200w structured abstract, PRISMA flowchart required)
- Pictorial Essay (1500w)
- Technical Note (1500w)
- Letter to the Editor / Reply (500w)
- Commentary (invited, 1200w)
- Editorial (invited, 1200w)
Classification
- Tier: Q2
- Open Access: Full OA (APC on acceptance: $1000 Meta-Analysis/Original, $1250 Review, $750 Pictorial Essay/Technical Note)
- Field: Radiology (diagnostic and interventional)
Special Notes
Turkish Society of Radiology official journal; double-blind review with mandatory statistics consultant for all original articles. Editorial office desk-returns for format non-compliance — critical items include 5-subheading capitalized structured abstract (PURPOSE/METHODS/RESULTS/CONCLUSION/CLINICAL SIGNIFICANCE), 3–5 Main Points between Abstract and Introduction, explicit IRB + informed consent statements in Methods (including N/A declarations for SR/MA), parenthetical (not superscript) references in AMA style, supplementary files as Word (not PDF), and iThenticate similarity ≤20% overall / ≤5% single-source. AI policy: follows ICMJE — disclose AI use in Methods.
Endocrinology and Metabolism
Identity
- Abbreviation: Endocrinol Metab (EnM)
- Publisher: Korean Endocrine Society (KES)
- ISSN: [TODO: verify at e-enm.org]
- Homepage: https://e-enm.org
- Author guidelines: https://e-enm.org/authors/authors.php
Scope
Endocrinology and Metabolism is the official English-language journal of the Korean Endocrine Society covering endocrinology, metabolism, hormonal disorders, thyroid, adrenal, pituitary, bone metabolism, diabetes, and lipid metabolism — clinical, epidemiological, and basic-science research. The journal is particularly receptive to Korean and East Asian population studies on endocrine disorders and to research with explicit hormonal-axis or endocrine-mechanism framing.
Scope Keywords
endocrinology, metabolism, thyroid disorders, adrenal disorders, pituitary disorders, bone metabolism, osteoporosis, diabetes mellitus, type 2 diabetes, lipid metabolism, dyslipidaemia, metabolic syndrome, hormonal axis, hormone replacement, Korean cohort, East Asian population, KES, mineral metabolism, calcium homeostasis, endocrine oncology
Article Types Accepted
- Original Article (abstract ≤250, refs ≤50)
- Review Article (abstract ≤200, refs ≤150)
- Brief Report (1,200 words, abstract ≤150 unstructured, refs ≤20, ≤2 figures)
- Editorial (1,000 words, refs ≤20)
- Image (1,000 words, refs ≤5)
- Letter to the Editor (1,000 words, refs ≤10, ≤1 figure)
Classification
- Tier: Q2 (specialty endocrinology journal)
- Open Access: Full OA, content freely available
- Field: Endocrinology / Metabolism / Hormonal Disorders
Special Notes
Endocrinology and Metabolism is the KES flagship English-language journal. Double-blind peer review with three anonymous specialist reviewers; review period capped at 3 months. Structured abstract (Background-Methods-Results-Conclusion) ≤250 words for Original Article. Reporting guidelines mandated per study design (CONSORT/STROBE/PRISMA/STARD). Figure resolution >300 DPI in JPEG/GIF/TIFF/BMP/PICT format with sequential Arabic numerals and letter sub-panels. AI policy: authors must clearly describe AI use in both manuscript and cover letter; AI cannot be listed as author; non-disclosure results in rejection or retraction. Particularly receptive to Korean and East Asian endocrinology studies and to research framed around hormonal-axis or endocrine-mechanism discussion. Body composition, diabetes, and metabolic syndrome research benefits from explicit endocrine framing in the manuscript narrative.
---
Verification
- Source: https://e-enm.org/authors/authors.php
- Date: 2026-05-21
European Journal of Preventive Cardiology (EJPC)
Identity
- Abbreviation: Eur J Prev Cardiol
- Publisher: Oxford University Press (on behalf of the European Association of Preventive Cardiology and the European Society of Cardiology)
- ISSN: 2047-4881 (online)
- Homepage: https://academic.oup.com/eurjpc
- Author guidelines: https://academic.oup.com/eurjpc/pages/general-instructions
Scope
EJPC addresses the causes and risk factors of cardiovascular diseases, as well as cardiovascular prevention, rehabilitation, exercise physiology and sport cardiology. The journal is the flagship outlet of the European Association of Preventive Cardiology (EAPC) within the European Society of Cardiology (ESC) family.
Scope Keywords
preventive cardiology, cardiovascular epidemiology, cardiovascular risk factors, primary prevention, secondary prevention, cardiac rehabilitation, exercise physiology, sport cardiology, lifestyle medicine, lipids, hypertension, diabetes, cardiovascular-kidney-metabolic, CKM staging, coronary artery calcium, subclinical atherosclerosis, cardiovascular screening, observational cohort, behavioral cardiology
Article Types Accepted
- Full Research Paper
- Clinical Practice / Education
- Review
- Editorial
- Rapid Communication
- Letter to the Editor
- Cardialogue
Classification
- Tier: Q1
- Open Access: Hybrid (subscription default; OA option available, APC not listed on the Author Guidelines page — verify at OUP open-access pricing portal)
- Field: Preventive cardiology — European society flagship
Special Notes
Full Research Papers are capped at 5,000 words, 6 figures/tables, and 100 references with a structured 250-word abstract using Aims / Methods / Results / Conclusion. References use Vancouver numbered style with first 6 authors listed; if more than 6, use 'et al.'. AI policy (verbatim): "Natural language processing tools driven by artificial intelligence (AI) do not qualify as authors, and the Journal will screen for them in author lists. The use of AI (for example, to help generate content or images, write code, process data, or for translation) should be disclosed in a cover letter at the point of submission and explained in full in a Methods or Acknowledgements section." Submission portal: https://www.editorialmanager.com/ejpc/default.aspx. EJPC is the natural home for cardiovascular prevention studies linking risk factor clustering to incident outcomes — including CKM staging, transition pattern, and early-metabolic-window analyses. Choose EJPC over JAHA when the primary framing is preventive (transitions, screening, lifestyle) rather than general cardiovascular outcomes, and over Atherosclerosis when the cohort design and prevention narrative outweigh the lipid/plaque-biology angle.
---
Verification
- Source: https://academic.oup.com/eurjpc/pages/general-instructions
- Date (harvested from private profile): 2026-05-20
- Date (promoted to public): 2026-05-21
European Radiology
Identity
- Abbreviation: Eur Radiol
- Publisher: Springer Nature (European Society of Radiology)
- ISSN: 0938-7994 / 1432-1084
- Homepage: https://www.springer.com/journal/330
- Author guidelines: https://www.springer.com/journal/330/submission-guidelines
Scope
European Radiology publishes original research and reviews across all subspecialties of diagnostic and interventional radiology, with emphasis on multi-center studies, AI/radiomics validation, and imaging innovations relevant to European and international clinical practice.
Scope Keywords
diagnostic radiology, interventional radiology, CT, MRI, ultrasound, radiomics, AI in radiology, multi-center studies, oncologic imaging, cardiac imaging, musculoskeletal imaging, neuroradiology, abdominal imaging, breast imaging, contrast agents, quantitative imaging
Article Types Accepted
- Original Article
- Review Article
- Technical Note
- Case Report
- Letter to the Editor
Classification
- Tier: Q1
- Open Access: Hybrid (Springer Open Choice)
- Field: Radiology (general)
Special Notes
European Radiology is the official journal of the European Society of Radiology (ESR) and one of the highest-impact general radiology journals. Requires 3 Key Points (max 85 characters each) as declarative statements. Uses British English throughout. Strongly prefers multi-center studies with N >= 200 for original articles. AI policy: follows ICMJE — disclose AI use in Methods. Graphical abstract mandatory from first revision for all Original Articles (Jan 2025). Official template: EURA-GA-Jan2025.pptx.
Hepatology Communications
Identity
- Abbreviation: Hepatol Commun
- Publisher: Wolters Kluwer Health, Inc. for AASLD (American Association for the Study of Liver Diseases)
- ISSN: 2471-254X (online-only, fully open access)
- Homepage: https://journals.lww.com/hepcomm
- Author guidelines: https://edmgr.ovid.com/hepcomm/accounts/ifauth.htm
- Submission portal: https://mc.manuscriptcentral.com/hepcomm
Scope
Hepatology Communications is the AASLD-published, peer-reviewed, online-only, fully open-access companion to Hepatology, dedicated to fast dissemination of high-quality basic, translational, and clinical research in hepatology. Authors retain copyright; articles are immediately and freely available to read and share.
Scope Keywords
hepatology, liver disease, MASLD, NAFLD, MASH, NASH, MetALD, ALD, alcohol-associated liver disease, chronic hepatitis B, chronic hepatitis C, HCC, hepatocellular carcinoma, cirrhosis, liver fibrosis, FIB-4, liver transplantation, basic hepatology, translational hepatology, clinical hepatology, MASLD nomenclature
Article Types Accepted
- Original Research Article (≤ 5,000 words; abstract 275 words; ≤ 50 references; ≤ 8 figures/tables)
- Review (≤ 5,000 words, invited preferred)
- Editorial (≤ 1,500 words; invited; "Viewpoints" unsolicited considered)
- Research Letter (≤ 1,000 words; clinical research only; no abstract; ≤ 10 refs; ≤ 1 table or figure)
- Correspondence (500–750 words)
- Special Articles (AASLD practice guidelines, in-depth reviews, social policy ≤ 5,000 words)
- Protocol Paper (pre-registered ongoing trials/studies; ≤ 5,000 words)
- Consensus Report (≤ 2,000 words; ≤ 9 refs)
Classification
- Tier: Q1 hepatology (AASLD family)
- Open Access: Full OA, mandatory CC BY or CC BY-NC-ND license
- Field: hepatology — basic, translational, clinical
Special Notes
AASLD's open-access companion to Hepatology — receives transferred submissions from Hepatology and other AASLD/Wiley liver journals, often with prior peer-review portable. Mandates the 2023 MASLD/MASH revised nomenclature in submitted manuscripts unless explicitly justified ("Manuscripts ... should employ this revised terminology wherever scientifically appropriate"). PaperPal Preflight pre-submission check available. STROBE checklist mandatory for cohort/cross-sectional studies. AI policy follows ICMJE: AI use must be disclosed in Materials and Methods AND cover letter, AI cannot be author, AI-generated text/images must be reviewed for accuracy by author who takes full responsibility. Initial submission allowed in single Word file with no strict formatting; revisions must use 1.5-spaced 10–12 pt body.
Article Processing Charges (verified from PDF, 2025 rates)
- Tier 1 (Articles, Reviews, Experimental Research): AASLD member US$1,890 / non-member US$3,150
- Tier 2 (Letters, Editorials, Correspondence): AASLD member US$480 / non-member US$800
Acceptance Rate (estimated)
~30–35 % (AASLD/Wiley OA companion typically more accepting than parent Hepatology; PubsHub editor reports 2024).
Hepatology International
Identity
- Abbreviation: Hepatol Int
- Publisher: Springer Nature on behalf of APASL (Asian Pacific Association for the Study of the Liver)
- ISSN: 1936-0533 / 1936-0541
- Homepage: https://link.springer.com/journal/12072
- Author guidelines: https://link.springer.com/journal/12072/submission-guidelines
- Editorial Manager: https://www.editorialmanager.com/heip
Scope
Hepatology International is the official journal of APASL, publishing original basic, translational, and clinical research in hepatology with strong representation of Asia-Pacific cohorts and disease patterns. Particularly prominent for MASLD/NAFLD natural history in East-Asian populations, chronic hepatitis B (regional endemic), HCC surveillance, and APASL-aligned guideline-relevant work.
Scope Keywords
hepatology, liver disease, MASLD, NAFLD, lean MASLD, MetALD, ALD, chronic hepatitis B, hepatitis C, HCC, hepatocellular carcinoma, cirrhosis, liver fibrosis, FIB-4, APASL guidelines, Asia-Pacific cohort, Asian liver disease, ACLF, acute-on-chronic liver failure, liver transplantation, biomarkers
Article Types Accepted
- Original Article (≤ 4,000 words including references; abstract 250 words structured; 10 keywords; graphical abstract MANDATORY; ≤ 30 references; ≤ 6 tables/figures combined)
- Review Article (≤ 5,000 words; abstract 250 words; ≤ 100 refs; ≥ 4 colored figures and ≥ 4 tables MANDATORY; total up to 8 illustrations)
- Mini Review (≤ 2,500 words excluding refs; abstract 150 words; ≤ 30 refs; ≥ 2 figures recommended; total up to 4 illustrations)
- Invited Article / Editorial (by invitation only; ≤ 1,500 words; ≤ 10 refs; 1 figure)
- Consensus Report (≤ 2,000 words; ≤ 9 refs)
- Letter to Editor (≤ 500 words; ≤ 5 refs; 1 figure)
- Point-of-View (by invitation; ≤ 1,500 words; ≤ 10 refs; 1 table + 2 figures)
- Commentary (by invitation; ≤ 1,500 words; ≤ 10 refs; 1 table + 1 figure)
- Multimedia / Dynamic Articles (with embedded video supplements ≤ 9 min)
Classification
- Tier: Q1 hepatology (APASL flagship)
- Open Access: Hybrid (OA optional via Springer's Open Choice; APC ~US$3,090 for OA)
- Field: hepatology — clinical and translational, Asia-Pacific emphasis
Special Notes
Copyright on accepted manuscripts is held by APASL (mandatory Copyright/Authorship/Disclosure Form signed by all authors at submission). Original Articles must include a single-panel graphical abstract (300 dpi+, .tif/.jpg, Arial 12–16 pt, RGB) placed next to abstract — labelled "Graphical Abstract" — this is one of the journal's strictest unique requirements. STROBE for cohort studies, PRISMA for SR/MA, STARD for diagnostic accuracy, ARRIVE for animals are required to be cited and uploaded as supplemental. Compliance with Ethical Requirements section (CoI / informed consent / human-and-animal-rights) goes on the title page only. Strong fit for Korean cohort epidemiology — sister society KASL is a long-standing APASL member, and Korean MASLD natural-history papers are well represented in recent volumes.
Acceptance Rate (estimated)
~25–30 % (Springer/APASL editor reports; Hepatol Int sits between CMH (KASL) and parent Hepatology in selectivity).
IEEE Journal of Biomedical and Health Informatics
Identity
- Abbreviation: IEEE J Biomed Health Inform, IEEE JBHI
- Publisher: IEEE (Institute of Electrical and Electronics Engineers)
- ISSN: 2168-2194 / 2168-2208
- Homepage: https://www.embs.org/jbhi/
- Author guidelines: https://www.embs.org/jbhi/author-information/
Scope
IEEE JBHI publishes research on information technology and its application to biomedical and health data. Coverage spans biomedical signal processing, wearable sensors, health monitoring, medical image analysis, bioinformatics, telemedicine, and AI-driven clinical decision support. The journal bridges electrical engineering, computer science, and health sciences.
Scope Keywords
biomedical signal processing, wearable sensors, health monitoring, ECG analysis, EEG analysis, medical image analysis, deep learning healthcare, IoT health, telemedicine, bioinformatics, clinical decision support, federated learning, edge computing health, physiological signals, health informatics
Article Types Accepted
- Regular Paper
- Short Paper
- Survey Paper
- Correspondence
Classification
- Tier: Q1
- Open Access: Hybrid (IEEE Open Access option)
- Field: Biomedical engineering / Health informatics
Special Notes
IEEE JBHI is one of the top IEEE journals for health-related AI and engineering research. It values technical depth in signal processing, systems engineering, and algorithm design alongside clinical relevance. The journal is strong in wearable/sensor-based health AI, federated learning for healthcare, and multimodal health data fusion. IEEE formatting and citation style required.
IEEE Transactions on Medical Imaging
Identity
- Abbreviation: IEEE Trans Med Imaging
- Publisher: IEEE (Institute of Electrical and Electronics Engineers)
- ISSN: 0278-0062 / 1558-254X
- Homepage: https://ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=42
- Author guidelines: https://www.embs.org/tmi/authors/
Scope
IEEE Transactions on Medical Imaging publishes original research on the formation, processing, and analysis of medical images. Coverage includes imaging physics, reconstruction algorithms, image segmentation, registration, detection, classification, and computer-aided diagnosis across all modalities (CT, MRI, PET, ultrasound, X-ray, microscopy, pathology). Emphasis is on algorithmic novelty and mathematical rigor with validation on medical imaging data.
Scope Keywords
medical imaging, image reconstruction, image segmentation, image registration, deep learning, convolutional neural networks, computed tomography, magnetic resonance imaging, ultrasound, pathology, computer-aided detection, object detection, image classification, self-supervised learning, transformer, generative models, physics-informed networks, federated learning
Article Types Accepted
- Regular Paper (12 pages, IEEE 2-column)
- Short Paper (6 pages)
- Correspondence (3 pages)
- Special Issue Papers
Classification
- Tier: Q1
- Open Access: Hybrid (IEEE OA option)
- Field: Medical imaging / Biomedical engineering
Special Notes
IEEE TMI uses strict page limits (12 pages including figures, tables, and references in IEEE 2-column format) rather than word limits. LaTeX with IEEEtran class is standard. The journal frequently publishes extended versions of MICCAI/ISBI conference papers (requiring 30%+ new content). Technical novelty in imaging methodology is required; clinical application alone without algorithmic contribution is insufficient. Papers typically include ablation studies, comparison with state-of-the-art, and computational cost analysis.
Interventional Neuroradiology
Identity
- Abbreviation: Interv Neuroradiol
- Publisher: SAGE Publications (ESMINT / WFITN)
- ISSN: 1591-0199 / 2385-2011
- Homepage: https://journals.sagepub.com/home/INI
- Author guidelines: https://journals.sagepub.com/author-instructions/INI
Scope
Interventional Neuroradiology publishes original research, reviews, and case reports on endovascular and minimally invasive neuroradiology, including cerebrovascular interventions, mechanical thrombectomy, aneurysm treatment, AVM embolization, and novel neurovascular devices.
Scope Keywords
neurointerventional radiology, mechanical thrombectomy, cerebral aneurysm, flow diversion, coiling, AVM embolization, dural arteriovenous fistula, carotid stenting, intracranial atherosclerosis, stroke intervention, venous sinus stenting, tumor embolization, spinal vascular intervention, neurovascular devices, endovascular treatment
Article Types Accepted
- Original Article
- Review Article
- Technical Note
- Case Report
- Letter to the Editor
Classification
- Tier: Q2
- Open Access: Hybrid (SAGE Choice)
- Field: Interventional neuroradiology
Special Notes
Interventional Neuroradiology is the official journal of ESMINT and WFITN, dedicated exclusively to minimally invasive neurovascular procedures. Accepts smaller case series (N=5-20) for novel techniques as technical notes. Requires explicit reporting of all complications including minor ones. Choose INSI over AJNR when the study is purely about interventional technique, devices, or endovascular outcomes. AI policy: follows ICMJE — disclose AI use in Methods.
Investigative Radiology
Identity
- Abbreviation: Invest Radiol
- Publisher: Wolters Kluwer / Lippincott Williams & Wilkins
- ISSN: 0020-9996 / 1536-0210
- Homepage: https://journals.lww.com/investigativeradiology/
- Author guidelines: https://journals.lww.com/investigativeradiology/pages/informationforauthors.aspx
Scope
Investigative Radiology publishes original research on novel imaging techniques, contrast agents, imaging physics, and translational imaging science, emphasizing early and timely publication of diagnostic imaging advances with high methodological rigor.
Scope Keywords
contrast agents, imaging physics, MRI techniques, CT technology, molecular imaging, quantitative imaging, imaging biomarkers, diffusion imaging, perfusion imaging, spectroscopy, photon-counting CT, dual-energy CT, ultrafast MRI, translational imaging, preclinical imaging, gadolinium
Article Types Accepted
- Original Research
Classification
- Tier: Q1
- Open Access: Hybrid (CC BY-NC-ND)
- Field: Radiology / Imaging science
Special Notes
Investigative Radiology is a highly selective journal focused on imaging science and technology rather than clinical case series. It does not accept case reports, reviews, or technical notes — only original research. Known for rapid publication of novel contrast agent studies and imaging physics advances. AI policy: AI use discouraged, must disclose in cover letter and Acknowledgments.
JACC: Advances
Identity
- Abbreviation: JACC Adv
- Publisher: Elsevier (on behalf of the American College of Cardiology)
- ISSN: 2772-963X (online; full open access)
- Homepage: https://www.sciencedirect.com/journal/jacc-advances
- Author guidelines: https://www.sciencedirect.com/journal/jacc-advances/publish/guide-for-authors
Scope
JACC: Advances provides a global forum for clinical research articles and timely reviews focused on advances in cardiovascular medicine. Content areas include arrhythmia and electrophysiology, cardio-obstetrics, cardiovascular surgery, congenital heart disease, coronary heart disease, critical care cardiology, digital health, genetics, geriatric cardiology, global health, health services research, heart failure, imaging, interventional cardiology, and other cardiovascular fields. The journal strives to appeal to authors across the spectrum of the cardiovascular care team at every career stage and considers original research articles, including applied clinical, epidemiological, and health care policy papers related to cardiovascular and cerebrovascular diseases.
Scope Keywords
cardiovascular medicine, cardiovascular research, epidemiology, prevention, cardio-metabolic, cardiovascular-kidney-metabolic, CKM staging, coronary artery calcium, cardiac CT, atherosclerosis, heart failure, hypertension, diabetes, dyslipidemia, screening cohort, observational study, health services research, digital health, global cardiology
Article Types Accepted
- Original Research Papers
- State-of-the-Art Reviews
- Methodology Corner
- Brief Reports
- Research Letters
- Viewpoints
- Letters to the Editor (and Replies)
- Editorial Comments
- JACC: Advances Expert Panel
Classification
- Tier: Emerging Q1 (JACC family, full open access)
- Open Access: Full Gold OA — APC USD 3,024 (Original Research / Reviews / Methodology / Expert Panel); USD 1,300 (Research Letters / Brief Reports). 10% discount for ACC members and early-career authors (≤10 years post-training); 50% discount for authors from developing countries.
- Field: Cardiovascular medicine — broad
Special Notes
Editor-in-Chief Candice K. Silversides, MD (University Health Network, University of Toronto). Original Research is capped at 5,000 words (including text, references, and figure legends) with a structured 250-word abstract using Background / Objectives / Methods / Results / Conclusions. State-of-the-Art Reviews and Expert Panels permit ≤10,000 words with an unstructured 150-word abstract; Brief Reports ≤1,200 words and Research Letters ≤1,000 words, each capped at 1 simple figure/table. References use Vancouver superscript numerals with "list all authors if 6 or fewer, otherwise list the first 3 and add et al." (journal titles italicized). The Guide for Authors does not display a journal-specific AI policy; Elsevier publisher-level policy applies — AI cannot be listed as an author, AI use in writing must be disclosed in a dedicated declaration immediately before the references, and AI may not be used to create or alter images. Submission portal: https://www.jaccsubmit-advances.org. As of 2026-05-20 the journal is not yet indexed for an Impact Factor (Web of Science indexing pending) — use it for novel framework applications where AHA-aligned editorial assessment is helpful and a global open-access audience matters more than IF.
---
Verification
- Source: https://www.sciencedirect.com/journal/jacc-advances/publish/guide-for-authors
- Date (harvested from private profile): 2026-05-20
- Date (promoted to public): 2026-05-21
JACC: Asia
Identity
- Abbreviation: JACC Asia
- Publisher: Elsevier (American College of Cardiology)
- ISSN: 2772-3747 (online)
- Homepage: https://www.jacc.org/journal/jacc-asia
- Author guidelines: https://www.sciencedirect.com/journal/jacc-asia/publish/guide-for-authors
Scope
JACC: Asia is the open-access sister journal in the JACC family devoted to cardiovascular research relevant to Asian populations and Asian healthcare systems. It publishes original investigations, state-of-the-art reviews, and clinical commentaries on epidemiology, prevention, imaging, interventional cardiology, electrophysiology, heart failure, and structural heart disease, with priority for Asian-data-driven evidence and Asia-Pacific clinical practice.
Scope Keywords
cardiovascular medicine, Asia-Pacific cardiology, coronary artery disease, coronary calcium, cardiac CT, cardiac MRI, atherosclerosis, heart failure, atrial fibrillation, hypertension, dyslipidemia, diabetes, MASLD, cardio-metabolic, structural heart disease, valvular heart disease, interventional cardiology, electrophysiology, prevention, Asian epidemiology, health screening
Article Types Accepted
- Original Investigation (Original Research)
- State-of-the-Art Review
- Mini-Focus / Special Series
- Research Letter
- Editorial / Viewpoint (invited)
- Letter to the Editor
Classification
- Tier: Emerging Q1 (JACC family; SCI indexing expected 2027, anticipated IF ~5–6)
- Open Access: Full Gold OA
- Field: Cardiovascular medicine — Asia-Pacific focus
Special Notes
JACC: Asia is the youngest member of the JACC family (launched 2021) and is positioned as the regional flagship for Asian cardiovascular evidence; Asian-data specificity, regional generalizability, and policy relevance to Asia-Pacific healthcare systems are explicitly weighed in editorial assessment. Original Investigations are capped at 5,000 words including text, references, and figure legends combined, with a 250-word structured abstract (Background/Objectives/Methods/Results/Conclusions). References use Vancouver superscript, list first 3 authors plus et al., and use Index Medicus abbreviations. AI policy: follows Elsevier/ICMJE — language editing only, must be disclosed in both the cover letter and the Acknowledgments, AI cannot be listed as author, and AI-generated images are not permitted unless explicitly declared.
Journal of the American College of Radiology
Identity
- Abbreviation: J Am Coll Radiol
- Publisher: Elsevier (American College of Radiology)
- ISSN: 1546-1440 / 1558-349X
- Homepage: https://www.jacr.org/
- Author guidelines: https://www.jacr.org/content/authorinfo
Scope
JACR publishes original research, opinions, and policy papers in five domains: health services research/policy, clinical practice management, data science, training/education, and leadership, focusing on how radiology is practiced, managed, and improved at the systems level.
Scope Keywords
health services research, radiology policy, imaging utilization, practice management, radiology workforce, value-based imaging, appropriateness criteria, clinical decision support, radiology education, quality metrics, patient safety, AI implementation, healthcare economics, radiology leadership, data science
Article Types Accepted
- Original Article
- Brief Report (invited only)
- Opinion
- Letter to the Editor
Classification
- Tier: Q1
- Open Access: Hybrid
- Field: Radiology / Health policy / Practice management
Special Notes
JACR is the official journal of the American College of Radiology, uniquely positioned at the intersection of radiology and health policy. Does not publish clinical reviews, book reviews, or case reports. Strict author limits (Original Article <= 7 authors). Requires a Summary Sentence (<35 words) and Take Home Points (3-6 bullets) instead of a traditional Conclusions section. AI policy: language editing only, must disclose use, AI cannot be listed as author.
JAMA Network Open
Identity
- Abbreviation: JAMA Netw Open
- Publisher: American Medical Association (AMA)
- ISSN: 2574-3805
- Homepage: https://jamanetwork.com/journals/jamanetworkopen
- Author guidelines: https://jamanetwork.com/journals/jamanetworkopen/pages/instructions-for-authors
Scope
JAMA Network Open is a fully open access, multidisciplinary journal publishing original research across all areas of medicine, including clinical care, innovation in health care, and global health. It publishes studies that advance medical knowledge, improve clinical practice, or inform health policy, accepting a broader range of study designs and sample sizes than JAMA.
Scope Keywords
clinical research, observational studies, randomized trials, health outcomes, health services research, global health, public health, epidemiology, medical AI, diagnostic accuracy, quality improvement, patient safety, disparities, digital health, cohort study
Article Types Accepted
- Original Investigation
- Research Letter
- Invited Commentary
- Systematic Review and Meta-Analysis
- Diagnostic/Prognostic Study
- US Preventive Services Task Force
Classification
- Tier: Q1
- Open Access: Full OA (APC ~$3,500)
- Field: General medicine (multidisciplinary)
Special Notes
JAMA Network Open is the most accessible high-impact general medical journal for original research. It accepts studies across all specialties including AI/radiology with clinical endpoints, diagnostic accuracy studies, and meta-analyses. Shares JAMA's structured abstract (7-heading) and Key Points box requirements. APC waiver available for LMIC authors. Acceptance rate ~15-20%. AI policy: language editing only, Methods + cover letter disclosure required per JAMA Network policy.
JAMA
Identity
- Abbreviation: JAMA
- Publisher: American Medical Association
- ISSN: 0098-7484 / 1538-3598
- Homepage: https://jamanetwork.com/journals/jama
- Author guidelines: https://jamanetwork.com/journals/jama/pages/instructions-for-authors
Scope
JAMA publishes original research, reviews, and opinion across all fields of medicine. It emphasizes studies with broad clinical relevance, public health implications, and policy impact. The journal values rigorous methodology, large-scale studies, and findings that inform clinical decision-making or health care delivery.
Scope Keywords
clinical research, public health, health policy, randomized controlled trial, epidemiology, clinical outcomes, therapeutics, preventive medicine, health equity, evidence-based medicine, screening, diagnosis, treatment, global health, medical education
Article Types Accepted
- Original Investigation
- Research Letter
- Review
- Clinical Review and Education
- Viewpoint
- Editorial
- Preliminary Communication
- Special Communication
- JAMA Diagnostic Test Interpretation
Classification
- Tier: Q1
- Open Access: Hybrid (optional OA)
- Field: General medicine
Special Notes
JAMA and JAMA Network journals (JAMA Internal Medicine, JAMA Surgery, JAMA Network Open, etc.) share a submission system. If rejected from JAMA, authors can transfer to a JAMA Network specialty journal. JAMA has a strong statistical review process and values structured reporting. Diagnostic accuracy studies and AI papers are considered if they demonstrate clear clinical utility.
AI Writing Disclosure Policy
- Requirement level: Required
- Permitted scope: Language editing only
- Disclosure location: Methods + Cover letter
- AI-generated images: Not specified — disclosure required if used
- Policy URL: https://jamanetwork.com/journals/jama/pages/instructions-for-authors#702720037
Journal of Cachexia, Sarcopenia and Muscle
Identity
- Abbreviation: J Cachexia Sarcopenia Muscle (JCSM)
- Publisher: Wiley
- ISSN: [TODO: verify at JCSM journal page]
- Homepage: https://onlinelibrary.wiley.com/journal/13989440
- Author guidelines: https://onlinelibrary.wiley.com/page/journal/13989440/homepage/forauthors.html
- Submission portal: https://authors.wiley.com/journal/JCSM/
Scope
The Journal of Cachexia, Sarcopenia and Muscle is the dedicated international journal for cachexia, sarcopenia, body composition, and skeletal-muscle and adipose-tissue physiology/pathophysiology across the lifespan and across chronic diseases (cancer, heart failure, lung disease, cirrhosis, kidney failure, rheumatoid arthritis, sepsis, AIDS). The journal serves researchers and clinicians studying muscle wasting, lipolysis, sarcopenic obesity, ageing-related body composition changes, and prognostic/diagnostic biomarkers for these conditions.
Scope Keywords
cachexia, sarcopenia, sarcopenic obesity, body composition, skeletal muscle, muscle wasting, adipose tissue, lipolysis, ageing, frailty, chronic disease, cancer cachexia, heart failure cachexia, COPD muscle wasting, cirrhosis sarcopenia, kidney failure cachexia, prognostic markers, body composition imaging, bioelectrical impedance, DXA, CT body composition, muscle biomarkers
Article Types Accepted
- Original Article (4,500 words, abstract 400 structured data-rich, refs 40, ≤8 figures/tables with max 6 sub-sections per figure)
- Review (6,000 words, abstract 400 unstructured data-rich, refs 120)
- Editorial (invited only; 1,500 words; Facts & Numbers series allows abstract up to 400 words)
- Research/Scientific Letter (1,200 words, 1 figure/table, 10 refs)
- Short Report (1,500 words, ≤2 figures/tables, 10 refs)
- Meeting Report (1,500 words, 20 refs)
- Reply / Letter to the Editor (1,200 words)
Classification
- Tier: Q1 (specialty journal — dedicated to cachexia/sarcopenia/body composition)
- Open Access: Gold OA, APC required on acceptance (waivers/discounts may apply)
- Field: Cachexia / Sarcopenia / Body Composition / Skeletal Muscle / Adipose Tissue
Special Notes
JCSM is the dedicated international journal for cachexia, sarcopenia, and body composition research, published by Wiley under Gold Open Access (APC required on acceptance). Single-blind peer review. Continuous publication model (articles publish to online issue when ready; no issue pagination delay). Title cap ≤17 words / 120 characters. Abstract must be data-rich (≤400 words, structured: Background/Methods/Results/Conclusions) with actual numbers, effect sizes, hazard ratios, 95% CIs, and p-values — "descriptive results abstracts are not acceptable." Original Article body ≤4,500 words; 40 references in main + unlimited supplement (S1, S2, ...). Only ONE corresponding author per submission; multiple co-first or equal-contribution requests must be declared in cover letter. For survival/prognostic studies, JCSM enforces strict reporting: 1-year mortality rate with 95% CI (plus 5-year and/or 3-month as appropriate) in both abstract AND methods/results; Kaplan-Meier plots with "patients at risk" annotation at baseline + follow-up intervals; novel prognostic markers expected from cohorts with ≥60–100 events, novel prognostic scores ≥150–200 events. Validation in second cohort strongly recommended. Reference style flexible (since August 2024) but must be consistent and complete (author, year, journal/book, article title, volume, pages, DOI optional). Preprints permitted (declare server + accession/DOI in cover letter). AI policy: [TODO: verify at journal AI policy page] — Wiley publisher-wide policy generally requires disclosure of AI tools and bars AI as author.
---
Verification
- Source: https://onlinelibrary.wiley.com/page/journal/13989440/homepage/forauthors.html
- Date: 2026-05-21
Journal of Korean Medical Science
Identity
- Abbreviation: J Korean Med Sci
- Publisher: Korean Academy of Medical Sciences (KAMS)
- ISSN: 1011-8934 (print) / 1598-6357 (electronic)
- Homepage: https://jkms.org
- Author guidelines: https://jkms.org (Author Information section)
- Submission portal: https://submit.jkms.org
Scope
JKMS publishes original research, reviews, case reports, and editorials across all medical specialties — clinical, basic-science, public-health, and epidemiology. The journal is the leading generalist English-language medical journal published by the Korean Academy of Medical Sciences with broad receptivity to Korean and East Asian population studies, single-institution observational research, and cross-disciplinary work with clear clinical implications.
Scope Keywords
general medicine, Korean population, East Asian medicine, clinical epidemiology, public health, observational cohort, retrospective cohort, single-institution study, IRB-approved retrospective study, cross-disciplinary medicine, MD-MD-research
Article Types Accepted
- Original Article (3,000 words, 6 figures)
- Review Article (invited, ≤6 figures)
- Brief Communication (1,500 words, 3 figures)
- Case Report (1,500 words, 4 figures)
- Case Conference for CME (2,500 words, 6 figures)
- Editorial / Opinion / Guideline (600–1,500 words)
- Correspondence (600 words, 1 figure)
Classification
- Tier: Q1 (generalist medical journal)
- Open Access: Full OA, indexed in PubMed/MEDLINE, SCIE, Scopus
- Field: General Medicine
Special Notes
JKMS is the flagship English-language generalist medical journal published by the Korean Academy of Medical Sciences, weekly online-only. References use Vancouver format with EndNote jkms.ens provided. Strict 3,000-word limit for original articles (Methods + Results + Discussion + Conclusion); abstract structured to 350 words (Background-Methods-Results-Conclusion). Submission requires title-page docx, main-body docx, tables/figures separate uploads, cover letter (addressed to EIC), per-author ICMJE COI, CRediT contributor declarations, and Data Availability Statement. APC charged on acceptance. AI policy follows ICMJE: disclose AI use in cover letter; AI cannot be listed as author. Typical review timeline ~8 weeks. Particularly receptive to Korean cohort studies with broad medical relevance and to single-institution observational work with clear clinical implications.
JMIR Medical Education
Identity
- Abbreviation: JMIR Med Educ
- Publisher: JMIR Publications
- ISSN: 2369-3762 (online only)
- Homepage: https://mededu.jmir.org/
- Author guidelines: https://mededu.jmir.org/author-instructions
Scope
Covers digital technology in medical and health professions education, including e-learning, simulation, AI-assisted teaching, virtual reality training, and online assessment. Bridges health informatics and education research with emphasis on technology-mediated learning innovations.
Scope Keywords
medical education technology, e-learning, simulation-based education, virtual reality training, artificial intelligence in education, online assessment, gamification, digital literacy, learning analytics, mobile learning, telemedicine education, virtual patients, augmented reality, large language models in education, competency-based digital education
Article Types Accepted
- Original Paper
- Review
- Viewpoint
- Policy Paper
- Students' Corner
Classification
- Tier: Q1
- Open Access: Full OA (CC BY 4.0)
- Field: Medical education technology
Special Notes
High-impact (IF ~12.6) JMIR sister journal focused on technology-enhanced medical education. Cascading peer review from JMIR flagship; single-blind with named reviewers published alongside accepted articles. Fast-track option (20 working days). AI policy: generative AI use must be disclosed per JMIR AI policy.
Journal of Medical Internet Research
Identity
- Abbreviation: J Med Internet Res
- Publisher: JMIR Publications
- ISSN: 1438-8871 (online only)
- Homepage: https://www.jmir.org/
- Author guidelines: https://www.jmir.org/author-instructions
Scope
Flagship journal of JMIR Publications covering digital health, health informatics, and emerging technologies applied to healthcare delivery. ML papers accepted only with direct clinical impact and independent validation. Pure clinical informatics without patient/consumer empowerment angle is routed to sister journals.
Scope Keywords
digital health, mHealth, telemedicine, health informatics, eHealth, wearable devices, patient engagement, clinical decision support, health apps, internet intervention, remote monitoring, online health communities, digital therapeutics, artificial intelligence in health, consumer health informatics, virtual care
Article Types Accepted
- Original Paper
- Digital Health Review
- Viewpoint/Perspective
- Research Letter
- Policy Paper
Classification
- Tier: Q1
- Open Access: Full OA (Gold)
- Field: Digital health / Health informatics
Special Notes
Ranked #1 in Medical Informatics by Google Scholar; highly selective with cascading peer review to JMIR sister journals. Fast-track option available (4-week turnaround). No bare URLs in body text — all must be cited as references. AI policy: follows ICMJE — disclose AI use in Methods.
Journal of NeuroInterventional Surgery
Identity
- Abbreviation: J NeuroIntervent Surg (JNIS)
- Publisher: BMJ Publishing Group / Society of NeuroInterventional Surgery (SNIS)
- ISSN: 1759-8478 (print) / 1759-8486 (online)
- Homepage: https://jnis.bmj.com
- Author guidelines: https://jnis.bmj.com/pages/authors/
Scope
JNIS publishes original research, reviews, and case material on endovascular and surgical neurointervention — acute ischemic stroke thrombectomy, intracranial aneurysm coiling and flow diversion, AVM and dAVF embolization, carotid and intracranial stenting, spine interventions, and emerging neurointerventional devices and techniques. The journal is the official journal of the Society of NeuroInterventional Surgery (SNIS) and partners with several international neurointerventional societies.
Scope Keywords
mechanical thrombectomy, intracranial aneurysm, flow diverter, coil embolization, arteriovenous malformation, dural arteriovenous fistula, carotid stenting, acute ischemic stroke intervention, endovascular treatment, neurointerventional device, stroke imaging, clot analysis, angiography, intracranial atherosclerosis
Article Types Accepted
- Original Research
- Review
- Case Series
- Brief Report
- Short Report
- Case Report (brief format)
- Technical Note / New Device
- Socioeconomics
- Editorial / Commentary
- Letter to the Editor / e-Letter
- Video Report
Classification
- Tier: Q1
- Open Access: Hybrid (optional Gold OA with APC; standard subscription route free to authors)
- Field: Neurointervention / endovascular neurosurgery / interventional neuroradiology
Special Notes
Official journal of SNIS. Peer review is double-anonymised — author identities removed from the manuscript file. ORCID iD is mandatory for the submitting author. Original Research requires a structured 250-word abstract and a "Key messages" summary box with three bullets (What is already known / What this study adds / How this study might affect research, practice or policy). Follows BMJ Tier 3 data-sharing policy: a Data Availability Statement is mandatory for all research articles. Reporting guideline adherence is required (STROBE/CONSORT/PRISMA/STARD/ARRIVE as applicable) and the completed checklist must be uploaded. Acceptance rate approximately 18% with a median first decision around 24 days (BMJ metrics, verify at submission). AI policy follows BMJ/ICMJE: generative AI cannot be listed as an author; any substantive use must be disclosed in Methods and/or Acknowledgments; AI-generated or -manipulated images are not permitted.
Journal of Biomedical Informatics
Identity
- Abbreviation: J Biomed Inform, JBI
- Publisher: Elsevier
- ISSN: 1532-0464 / 1532-0480
- Homepage: https://www.sciencedirect.com/journal/journal-of-biomedical-informatics
- Author guidelines: https://www.elsevier.com/journals/journal-of-biomedical-informatics/1532-0464/guide-for-authors
Scope
Journal of Biomedical Informatics publishes research on computational and informatics methods applied to biomedical data. Coverage includes clinical informatics, health information systems, electronic health records, clinical NLP, knowledge representation, decision support systems, and data science applied to health data. It bridges computer science and clinical medicine through information technology.
Scope Keywords
biomedical informatics, clinical informatics, electronic health records, clinical decision support, natural language processing, health data science, knowledge representation, ontology, phenotyping, clinical NLP, EHR, prediction models, machine learning clinical data, patient outcomes, data integration
Article Types Accepted
- Original Research
- Review Article
- Methodological Review
- Short Communication
- Special Communication
Classification
- Tier: Q1
- Open Access: Hybrid
- Field: Medical informatics
Special Notes
JBI is distinguished from image-focused AI journals by its emphasis on structured clinical data (EHR, claims, lab results) rather than imaging data. It values methodological rigor and clinical applicability. Studies on large language models for clinical NLP, clinical prediction models, and health information exchange are well-suited. The journal requires clear description of data provenance and clinical context.
The Journal of Clinical Endocrinology & Metabolism (JCEM)
Identity
- Abbreviation: J Clin Endocrinol Metab
- Publisher: Oxford University Press (on behalf of the Endocrine Society)
- ISSN: 0021-972X (print) / 1945-7197 (online)
- Homepage: https://academic.oup.com/jcem
- Author guidelines: https://academic.oup.com/jcem/pages/Author_Guidelines
Scope
JCEM positions itself as "the world's leading peer-reviewed journal for endocrine clinical research and clinical practice." Article types span original research, reviews, case reports, commentaries, and consensus statements covering endocrinology, metabolism, diabetes, thyroid, bone, reproductive endocrinology, and adrenal/pituitary disease.
Scope Keywords
clinical endocrinology, metabolism, diabetes, thyroid, bone disease, reproductive endocrinology, adrenal disease, pituitary disease, metabolic syndrome, insulin resistance, cardio-metabolic, obesity, lipid metabolism, cardiovascular-kidney-metabolic, CKM staging
Article Types Accepted
- Clinical Research Article (Original)
- Approach to the Patient
- Mini-review
- Meta-analysis
- Editorial
- Commentary
- Letter to the Editor
- Report and Recommendation (society/consensus)
Classification
- Tier: Q1 (Endocrine Society flagship)
- Open Access: Hybrid — page charge model (USD 99–119 per PDF page member/non-member; color figure surcharge USD 235–735); open access option separate via OUP open-access portal
- Field: Clinical endocrinology and metabolism
Special Notes
Editor-in-Chief Paul M. Stewart, MD. Original Articles do not have a stated upper word limit (Approach to the Patient 2,000–5,000 words; Mini-reviews 2,000–5,000 words). Required 250-word structured abstract describing purpose, methods, results, and main conclusions in complete sentences without direct text references. References use AMA citation style with consecutive numerical ordering and the guideline states "List all authors for the initial submission" (no first-N-then-et-al truncation at submission stage). AI policy (verbatim): "The use of artificial intelligence (AI) tools must be disclosed during the submission process and also described in the Methods or Acknowledgments sections of the text." Reviewers are explicitly prohibited from uploading any part of a manuscript into LLM tools during review. Submission portal: https://www.editorialmanager.com/jcem/. Choose JCEM when the metabolic-syndrome / insulin-resistance / cardio-metabolic mechanism is the primary scientific contribution and cardiovascular outcomes serve a supporting role (rather than the inverse).
---
Verification
- Source: https://academic.oup.com/jcem/pages/Author_Guidelines
- Date (harvested from private profile): 2026-05-20
- Date (promoted to public): 2026-05-21
Journal of Magnetic Resonance Imaging
Identity
- Abbreviation: JMRI, J Magn Reson Imaging
- Publisher: Wiley (International Society for Magnetic Resonance in Medicine)
- ISSN: 1053-1807 / 1522-2586
- Homepage: https://onlinelibrary.wiley.com/journal/15222586
- Author guidelines: https://onlinelibrary.wiley.com/page/journal/15222586/homepage/forauthors.html
Scope
JMRI publishes original research on all aspects of magnetic resonance imaging in medicine, including technical development, clinical applications, and translational research. It covers MRI across all body systems and disease categories, with particular strength in musculoskeletal, neuroimaging, abdominal, and cardiac MRI.
Scope Keywords
magnetic resonance imaging, MRI, MR technique, diffusion-weighted imaging, perfusion imaging, MR spectroscopy, contrast agents, gadolinium, liver MRI, cardiac MRI, musculoskeletal MRI, neuroimaging, quantitative MRI, radiomics, deep learning MRI
Article Types Accepted
- Original Research
- Technical Note
- Review Article
- Case Report (as Brief Report)
- Letter to the Editor
- Pictorial Essay
Classification
- Tier: Q1
- Open Access: Hybrid
- Field: Radiology / MRI
Special Notes
JMRI is the official journal of ISMRM and is the premier MRI-focused journal. It strongly favors studies with MRI-specific technical innovation or clinical validation. AI studies focused on MRI data (segmentation, detection, quantification) are welcomed. The journal values reproducibility and encourages sharing of code and data.
Journal of Medical Case Reports
Identity
- Abbreviation: J Med Case Rep
- Publisher: BMC (Springer Nature)
- ISSN: 1752-1947 (electronic)
- Homepage: https://jmedicalcasereports.biomedcentral.com/
- Author guidelines: https://jmedicalcasereports.biomedcentral.com/submission-guidelines
Scope
The first international, PubMed-indexed journal devoted exclusively to publishing case reports across all medical disciplines. It welcomes single-patient reports and small case series from any specialty, with particular value placed on cases that add to clinical knowledge, illustrate diagnostic or therapeutic lessons, or describe rare presentations and adverse events.
Scope Keywords
case report, case series, rare disease, diagnostic dilemma, adverse drug reaction, unusual presentation, clinical lesson, multidisciplinary, all specialties, patient-centered
Article Types Accepted
- Case Report
- Case Series
- Case Report with literature review
Classification
- Tier: Q3 (case-report-dedicated)
- Open Access: Full gold OA, CC BY 4.0 (APC applies — verify current amount)
- Field: General medicine / case reports (all specialties)
Special Notes
Mandatory CARE-aligned structure (Background, Case presentation, Discussion/Conclusions) and written informed consent for publication (a copy must be available to the Editor-in-Chief). Encourages the patient's perspective where feasible. Ethics approval or a documented waiver basis is expected for the report. A strong default home when a case does not fit a specialty journal.
Verification
Identity (publisher, ISSN, OA/CC-BY, CARE + consent requirement) verified 2026-06-15 against a current CC-BY article in the journal (Europe PMC) and the public author-guidelines URL. Specific word/figure/reference limits and the current APC were not independently fetched (publisher page auth-gated) — confirm at the guidelines URL before submission.
Journal of Nuclear Medicine
Identity
- Abbreviation: JNM, J Nucl Med
- Publisher: Society of Nuclear Medicine and Molecular Imaging (SNMMI)
- ISSN: 0161-5505 / 2159-662X
- Homepage: https://jnm.snmjournals.org/
- Author guidelines: https://jnm.snmjournals.org/page/author-instructions
Scope
JNM publishes original research in nuclear medicine, molecular imaging, and theranostics. Coverage includes PET, SPECT, radionuclide therapy, radiopharmaceuticals, and hybrid imaging (PET/CT, PET/MRI). The journal emphasizes clinical and translational studies involving radiotracer development, dosimetry, and molecular-targeted diagnostics and therapies.
Scope Keywords
nuclear medicine, PET, SPECT, PET/CT, PET/MRI, radionuclide therapy, theranostics, radiopharmaceuticals, FDG, PSMA, molecular imaging, dosimetry, radiotracer, oncology imaging, neuroendocrine tumors
Article Types Accepted
- Original Research (Clinical and Basic Science)
- Brief Communication
- Review Article
- State of the Art
- Case Report (Interesting Image)
- Letters to the Editor
- Continuing Education
Classification
- Tier: Q1
- Open Access: Hybrid (author choice)
- Field: Nuclear medicine / Molecular imaging
Special Notes
JNM is the flagship journal of nuclear medicine. It has strong interest in theranostics (PSMA, Lu-177, etc.) and novel radiotracer development. AI applications in nuclear medicine (automated quantification, lesion detection on PET) are increasingly published. The journal has a companion publication, Journal of Nuclear Medicine Technology.
Journal of Stroke
Identity
- Abbreviation: J Stroke
- Publisher: Korean Stroke Society
- ISSN: 2287-6391 (print) / 2287-6405 (online)
- Homepage: http://j-stroke.org
- Author guidelines: https://j-stroke.org/authors/authors.php
Scope
Journal of Stroke publishes original research, reviews, guidelines, and special reports on cerebrovascular disease, including epidemiology, risk factors, pathophysiology, diagnosis, acute treatment, secondary prevention, neurorehabilitation, and stroke systems of care. The journal prioritizes clinically translatable work and welcomes international submissions, with a strong tradition of regional stroke research from Asia.
Scope Keywords
ischemic stroke, hemorrhagic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, transient ischemic attack, acute stroke treatment, thrombolysis, mechanical thrombectomy, stroke prevention, cerebrovascular imaging, cerebral small vessel disease, stroke epidemiology, stroke outcome, neurorehabilitation, stroke guideline
Article Types Accepted
- Special Review
- Review
- Original Article
- Guideline
- Special Report
- Editorial
- Letter to the Editor
- Response to Letter
Classification
- Tier: Q1
- Open Access: Full OA (CC BY-NC 4.0, no APC)
- Field: Stroke / cerebrovascular disease
Special Notes
Official journal of the Korean Stroke Society, published three times per year. Full open access with no article processing charge — a rare combination for a Q1 stroke journal. Editorial Office is hosted at Asan Medical Center, Ulsan University College of Medicine. Structured abstract of 250 words required for Original Articles; references follow Vancouver numbered style. Choose Journal of Stroke over Stroke (AHA) when the target audience is regional (Asia-Pacific) or when no-APC OA is a priority. AI policy: not specified in the author guidelines (last revised 2024-01-31); default to ICMJE — disclose any AI-assisted writing in Methods or Acknowledgments.
Journal of Vascular and Interventional Radiology
Identity
- Abbreviation: J Vasc Interv Radiol
- Publisher: Elsevier (SIR — Society of Interventional Radiology)
- ISSN: 1051-0443 / 1535-7732
- Homepage: https://www.jvir.org/
- Author guidelines: https://www.jvir.org/content/authorinfo
Scope
JVIR publishes original research, reviews, meta-analyses, and technical reports on vascular and interventional radiology. Coverage spans all IR procedures including embolization, ablation, vascular access, drainage, thrombolysis, and emerging minimally invasive techniques. The journal also covers quality improvement, practice standards, and clinical outcomes research in IR.
Scope Keywords
interventional radiology, vascular interventions, embolization, tumor ablation, percutaneous biopsy, drainage, thrombolysis, IVC filter, venous access, TIPS, TACE, Y-90 radioembolization, IR outcomes, complication classification, quality improvement, standards of practice, image-guided therapy
Article Types Accepted
- Clinical Investigation
- Clinical Practice
- Technical Report
- Case Report
- Review Article
- Systematic Review / Meta-Analysis
- Letter to the Editor
Classification
- Tier: Q2
- Open Access: Hybrid (Elsevier OA option)
- Field: Radiology / Interventional radiology
Special Notes
JVIR is the official journal of the Society of Interventional Radiology (SIR). SIR complication classification is mandatory for procedure studies. The journal publishes SIR standards of practice documents and quality improvement studies. JVIR has a North American and international readership. For European-focused IR studies or CBCT-guided intervention meta-analyses, consider CVIR as an alternative or companion target.
Korean Journal of Radiology
Identity
- Abbreviation: Korean J Radiol
- Publisher: Korean Society of Radiology
- ISSN: 1229-6929 (Print) / 2005-8330 (Electronic)
- Homepage: https://www.kjronline.org/
- Author guidelines: https://www.kjronline.org/index.php?body=Instruction
Scope
KJR publishes original research, reviews, and special articles across all subspecialties of diagnostic and interventional radiology. The journal explicitly excludes radiation oncology, dentistry, dental radiology, dental surgery, and translational/basic nuclear medicine studies. It has particular strength in AI/radiomics, Korean and East Asian population studies, and diseases prevalent in East Asia such as hepatocellular carcinoma, gastric cancer, and thyroid cancer.
Scope Keywords
diagnostic radiology, AI in radiology, radiomics, deep learning, Korean radiology, hepatocellular carcinoma, thyroid imaging, gastric cancer imaging, CT, MRI, ultrasound, interventional radiology, liver imaging, breast imaging, chest imaging, structured reporting, FDA/medical-device evaluation
Article Types Accepted
- Original Article
- Brief Research Report
- Review
- Pictorial Essay
- Focus
- Recommendation and Guideline
- Editorial
- Uncover This Tech Term
- Emerging Rad Dx
- Letter to the Editor
Classification
- Tier: Q1
- Open Access: Full OA (CC BY-NC 4.0, DOAJ indexed)
- Field: Radiology (general)
Special Notes
KJR is the leading English-language radiology journal in Asia, fully open access (USD 100 APC for accepted manuscripts; invited articles, Uncover This Tech Term, Emerging Rad Dx, and Letters are exempt). Indexed in PubMed/MEDLINE, SCIE, and Scopus. Particularly receptive to AI/radiomics studies and Korean population data. Faster turnaround than Western journals (Minor Revision within 30 days; Major Revision within 60 days). References: Vancouver style with first six authors listed, then "et al." (≥7 authors). AI policy follows the journal's "Ethical and Responsible Use of Generative AI" statement (KJR 2026; https://doi.org/10.3348/kjr.2026.0166): AI cannot be author or primary scholarly source; AI use beyond routine language assistance must be disclosed in the relevant section or Acknowledgments; AI as study subject must be described in Materials and Methods; reviewers/editors must preserve confidentiality and disclose AI use beyond routine language assistance.
Verification
- Source: KJR-Instructions-202603.pdf (March 2026 official author instructions)
- Date: 2026-05-21
Korean Circulation Journal (KCJ)
Identity
- Abbreviation: Korean Circ J
- Publisher: The Korean Society of Cardiology / The Korean Cardiac Research Foundation
- ISSN: 1738-5520 (print) / 1738-5555 (online)
- Homepage: https://e-kcj.org/
- Author guidelines: https://e-kcj.org/index.php?body=instructions
Scope
KCJ is the official journal of the Korean Society of Cardiology, covering all aspects of cardiovascular medicine including original research of preclinical and clinical findings, state-of-the-art reviews, perspectives for outbreaking issues, editorials, images in cardiovascular medicine, and letters to the editor.
Scope Keywords
cardiology, cardiovascular disease, Korean cohort, clinical cardiology, coronary artery disease, atherosclerosis, heart failure, arrhythmia, hypertension, preventive cardiology, cardiac imaging, Asian cardiology, KSC official journal
Article Types Accepted
- Original Research
- State of the Art Review
- Perspective
- Image in Cardiovascular Medicine
- Letter to the Editor
- Research Letter
Classification
- Tier: Q3 (Korean society flagship)
- Open Access: Open Access, peer-reviewed, monthly
- Field: Cardiology — Korean Society of Cardiology flagship
Special Notes
Editor-in-Chief In-Ho Chae, MD, PhD. Original Research capped at 5,000 words, 8 figures/tables, with a 250-word structured abstract using Background and Objectives / Methods / Results / Conclusions. State of the Art Reviews ≤10,000 words. Perspectives ≤2,000 words, 4 figures/tables; Research Letter ≤800 words, 1 figure/table; Letter to the Editor ≤500 words. References use Vancouver style with numbered references in citation order; "List all authors if 6 or fewer; otherwise, list the first 3 and add et al." Submission portal: https://kcj.edmgr.com. AI policy is not displayed on the Instructions for Authors page as of the audit date — refer directly to KCJ's editorial office for AI disclosure expectations. APC not specified on the guidelines page; verify at the journal's open-access policy page if Gold OA is needed. Natural home for Korean cardiovascular cohort papers that need a guaranteed publication path and KSC community visibility — best used as a safety-net target in a cascade strategy or as primary when Korean clinical-practice relevance is the dominant framing.
---
Verification
- Source: https://e-kcj.org/index.php?body=instructions
- Date (harvested from private profile): 2026-05-20
- Date (promoted to public): 2026-05-21
Korean Journal of Internal Medicine
Identity
- Abbreviation: KJIM
- Publisher: Korean Association of Internal Medicine
- ISSN: 1226-3303 / 2005-6648
- Homepage: https://www.kjim.org/
- Author guidelines: https://www.kjim.org/authors/authors.php
Scope
KJIM publishes original research, reviews, and clinical case reports across all subspecialties of internal medicine — endocrinology, gastroenterology, hematology-oncology, infectious diseases, nephrology, pulmonology, rheumatology, cardiology, geriatrics — with emphasis on Korean and East Asian clinical research.
Scope Keywords
internal medicine, Korean cohort, East Asian medicine, endocrinology, gastroenterology, hematology, oncology, infectious disease, nephrology, pulmonology, rheumatology, cardiology, geriatrics, health screening, NHIS, clinical research, observational cohort
Article Types Accepted
- Original Article
- Review
- Editorial
- Images of Interest
- Correspondence
Classification
- Tier: Q2 (general internal medicine; verify current JCR rank)
- Open Access: Full OA (CC BY-NC); APC $1,000 for Original Articles (2024-10-01)
- Field: Internal medicine (general)
Special Notes
Korean Association of Internal Medicine flagship; bimonthly publication; PubMed/PMC indexed; structured abstract requires Background/Aims, Methods, Results, Conclusions; KJIM-specific "Key Message" section is mandatory in Original Articles. Initial decision typically within 4 weeks. AI policy: mandatory AI disclosure in Acknowledgments with model name + version + source + application method; AI cannot be listed as author.
---
Verification
- Source: https://www.kjim.org/authors/authors.php
- Date: 2026-05-21
Lancet Diabetes & Endocrinology
Identity
- Abbreviation: Lancet Diabetes Endocrinol
- Publisher: Elsevier (The Lancet Group)
- ISSN: 2213-8587 / 2213-8595
- Homepage: https://www.thelancet.com/journals/landia/home
- Author guidelines: https://www.thelancet.com/landia/information-for-authors
Scope
Lancet Diabetes & Endocrinology publishes original research, reviews, and clinical studies in diabetes, endocrinology, and metabolism. Coverage includes type 1 and type 2 diabetes, obesity, thyroid disorders, adrenal disorders, pituitary disease, bone and mineral metabolism, reproductive endocrinology, and metabolic syndrome. The journal prioritizes large clinical trials, epidemiological studies, and translational research with global health implications.
Scope Keywords
diabetes mellitus, type 2 diabetes, type 1 diabetes, obesity, thyroid disease, endocrinology, metabolic syndrome, insulin resistance, GLP-1 receptor agonist, HbA1c, diabetic complications, adrenal insufficiency, Cushing syndrome, osteoporosis, pituitary adenoma, PCOS, gestational diabetes
Article Types Accepted
- Original Research (Articles)
- Review
- Series
- Seminar
- Comment
- Correspondence
- Clinical Picture
- Viewpoint
Classification
- Tier: Q1
- Impact Factor: ~42
- Open Access: Hybrid
- Field: Endocrinology / Diabetes
Special Notes
Lancet Diabetes & Endocrinology is the premier endocrinology/diabetes specialty journal within the Lancet family. Extremely competitive (acceptance rate <10%). Publishes landmark diabetes trials (e.g., SGLT2 inhibitor, GLP-1 RA outcomes). Imaging studies accepted only when part of major clinical trials (e.g., body composition imaging, pancreatic imaging in diabetes). Follows Lancet Group editorial standards: strict adherence to ICMJE, EQUATOR checklists mandatory, and preference for large multicenter international RCTs or prospective cohorts.
AI Writing Disclosure Policy
- Requirement level: Required
- Permitted scope: Restrictive — Lancet Group policy permits AI for language editing only; AI cannot contribute to scientific content generation; AI cannot be listed as author
- Disclosure location: Acknowledgments section
- AI-generated images: Not permitted for scientific content
- Policy URL: https://www.thelancet.com/landia/information-for-authors
Lancet Gastroenterology & Hepatology
Identity
- Abbreviation: Lancet Gastroenterol Hepatol
- Publisher: Elsevier (The Lancet Group)
- ISSN: 2468-1253
- Homepage: https://www.thelancet.com/journals/langas/home
- Author guidelines: https://www.thelancet.com/langas/information-for-authors
Scope
The Lancet Gastroenterology & Hepatology publishes original research, reviews, comments, and clinical studies across the full spectrum of gastroenterology and hepatology. The journal favors large clinical trials, multicentre or population-scale epidemiology, evidence-synthesis (Cochrane-style and individual-patient-data meta-analyses), and translational studies with global health implications. Within hepatology it has been a primary venue for MASLD/NAFLD natural-history evidence (e.g., Hagström 2024 systematic review of natural-history rates), nomenclature debate following the 2023 multisociety Delphi statement, hepatitis B/C elimination programmes, and cirrhosis/portal-hypertension management trials.
Scope Keywords
gastroenterology, hepatology, MASLD, NAFLD, MASH, MetALD, ALD, alcohol-associated liver disease, viral hepatitis, hepatitis B, hepatitis C, HCC, hepatocellular carcinoma, cirrhosis, portal hypertension, IBD, Crohn's disease, ulcerative colitis, irritable bowel syndrome, gastrointestinal cancer, liver transplantation, FIB-4, natural history, comparator-refinement methodology, large-cohort epidemiology, Cochrane meta-analysis
Article Types Accepted
- Articles (Original Research; large RCTs, observational cohort, IPD meta-analysis)
- Review
- Series (commissioned thematic series)
- Seminar
- Comment (invited editorial)
- Correspondence
- Clinical Picture
- Viewpoint
- Personal View
Classification
- Tier: Q1 gastroenterology and hepatology (top-tier specialty journal in Lancet group)
- Open Access: Hybrid (OA optional; APC ~US$5,500 for Gold OA)
- Field: gastroenterology and hepatology — clinical, epidemiological, translational
Special Notes
Submission guidelines are a near-verbatim shared template across the Lancet Group specialty journals (Lancet Diabetes & Endocrinology, Lancet GH, Lancet Respiratory Medicine, etc.) — same article structure, abstract, statement-of-novelty wording, AI policy, and supplementary requirements. Beyond what the guidelines disclose, the practically relevant non-guideline factors for this venue are documented below.
Editorial culture (non-guideline)
- Pre-submission inquiry strongly advised. ~60–70 % desk-reject rate for original research; pre-submission inquiry (1-page abstract + cover letter to editor@lancet.com) is the standard route to test scope fit before full submission. Decisions on inquiries typically arrive within 5–10 working days.
- Strong preference for "what changes practice or guideline" framing in cover letter and Discussion. Methodology-only papers (e.g., comparator refinement as method) need an explicit "how this will change MASLD natural-history evidence appraisal worldwide" paragraph.
- Research in Context box mandatory at acceptance (separate from abstract): three sub-headings (Evidence before this study / Added value of this study / Implications of all the available evidence). Drafting it pre-submission helps internal triage even though it is not officially required at initial submission.
- Statement of novelty / data-sharing statement mandatory in cover letter (not in main paper). Lancet Group requires deposition pathway specified at submission, not at revision.
MASLD-natural-history precedent
- The journal has been the de-facto reference venue for MASLD natural-history evidence since 2024 (Hagström L, et al. Clinical and prognostic outcomes after hepatocellular cancer screening, Lancet Gastroenterol Hepatol; and the post-2023 Delphi nomenclature commentaries). A Korean health-screening cohort applying the 2023 nomenclature with comparator-refinement methodology is a direct continuation of that line of evidence.
- Reviewer pool overlaps substantially with Hepatology (AASLD), Journal of Hepatology (EASL), and Hepatology International (APASL). Suggested reviewers from these venues are typical.
Korean cohort context
- East-Asian cohort epidemiology is regularly published, but the journal has a documented preference for international or multi-cohort validation (e.g., paired Korean + UK Biobank + NHANES analyses). Single-centre Korean cohorts are accepted when the methodological contribution (e.g., comparator refinement as a generalizable method) is strong enough to justify international relevance — the cover letter should pre-empt the "single-centre / Asian-only" reviewer concern.
Acceptance Rate (estimated)
~5–8 % overall (Lancet specialty journals' published acceptance bands; ~60–70 % desk-rejected before peer review, of the remainder ~25–35 % accepted).
The Lancet Infectious Diseases
Identity
- Abbreviation: Lancet Infect Dis
- Publisher: Elsevier (Lancet Group)
- ISSN: 1473-3099 / 1474-4457
- Homepage: https://www.thelancet.com/journals/laninf
- Author guidelines: https://www.thelancet.com/laninf/information-for-authors
Scope
The Lancet Infectious Diseases publishes high-impact original research, reviews, and commentary on all aspects of infectious diseases, including clinical, public health, and microbiological perspectives. It prioritizes studies with global health significance, large-scale trials, and translational findings relevant to infection prevention, diagnosis, and treatment.
Scope Keywords
infectious diseases, global health, antimicrobial resistance, vaccines, HIV/AIDS, tuberculosis, malaria, emerging infections, pandemic preparedness, clinical trials, epidemiology, infection control, antimicrobial stewardship, neglected tropical diseases, outbreak response, diagnostics, public health interventions
Article Types Accepted
- Original Research (Articles)
- Review
- Personal View
- Comment
- Correspondence
- Series
- Health Policy
Classification
- Tier: Q1
- Open Access: Hybrid (optional OA)
- Field: Infectious diseases
Special Notes
The Lancet Infectious Diseases is the leading specialty journal in ID with IF ~31. It shares the Lancet Group submission system and editorial standards; manuscripts rejected from The Lancet may be transferred. The journal strongly favors large multicenter trials, systematic reviews with global scope, and policy-relevant epidemiological studies.
AI Writing Disclosure Policy
- Requirement level: Required
- Permitted scope: Language editing only (not intellectual contribution)
- Disclosure location: Acknowledgments
- AI-generated images: Not permitted without disclosure
- Policy URL: https://www.thelancet.com/laninf/information-for-authors
Lancet Neurology
Identity
- Abbreviation: Lancet Neurol
- Publisher: Lancet / Elsevier
- ISSN: 1474-4422 / 1474-4465
- Homepage: https://www.thelancet.com/journals/laneur/home
- Author guidelines: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(00)X0015-0/fulltext
Scope
The Lancet Neurology publishes original research, reviews, and personal views across all areas of clinical neurology and neuroscience with clinical relevance. Coverage includes stroke, dementia, epilepsy, movement disorders, multiple sclerosis, neuro-oncology, neuromuscular disease, neuroinfection, and headache. The journal prioritizes large-scale clinical trials, major epidemiological studies, and translational research that advances patient care in neurological disease.
Scope Keywords
neurology, stroke, dementia, Alzheimer disease, epilepsy, Parkinson disease, multiple sclerosis, movement disorders, neuro-oncology, neuromuscular disease, headache, traumatic brain injury, neuroimmunology, clinical neuroscience, neurodegeneration
Article Types Accepted
- Original Research (Articles)
- Review
- Series
- Seminar
- Personal View
- Comment
- Correspondence
Classification
- Tier: Q1
- Impact Factor: ~45
- Open Access: Hybrid
- Field: Neurology
Special Notes
The Lancet Neurology is the highest-impact specialty neurology journal. It shares the Lancet Group editorial policies, formatting requirements, and submission platform. Manuscripts must have a structured Summary (Background, Methods, Findings, Interpretation, Funding). The journal is highly selective (~5% acceptance) and favors multicenter RCTs, landmark cohort studies, and comprehensive systematic reviews that shape clinical practice or guidelines.
AI Writing Disclosure Policy
- Requirement level: Required
- Permitted scope: AI tools may assist with writing but cannot be authors; authors retain full responsibility
- Disclosure location: Acknowledgments or Methods section
- AI-generated images: Must be disclosed
- Policy URL: https://www.thelancet.com/pb/assets/raw/Lancet/authors/lancet-information-for-authors.pdf
Lancet Oncology
Identity
- Abbreviation: Lancet Oncol
- Publisher: Lancet / Elsevier
- ISSN: 1470-2045 / 1474-5488
- Homepage: https://www.thelancet.com/journals/lanonc
- Author guidelines: https://www.thelancet.com/lanonc/information-for-authors
Scope
Lancet Oncology publishes original research, reviews, and policy-focused content in clinical and translational oncology. It prioritizes large-scale international clinical trials, practice-changing therapeutic advances, cancer prevention and screening, and global oncology health policy. As part of the Lancet family, it values broad clinical impact, global health perspectives, and evidence that shapes cancer care delivery worldwide.
Scope Keywords
clinical oncology, cancer, clinical trial, immunotherapy, targeted therapy, radiation oncology, surgical oncology, cancer prevention, screening, global oncology, health policy, precision medicine, cancer genomics, biomarkers, cancer epidemiology, survivorship, international multicenter, translational oncology
Article Types Accepted
- Article (Original Research)
- Review
- Series
- Viewpoint
- Comment
- Correspondence
- Personal View
- Commission
Classification
- Tier: Q1
- Impact Factor: ~36
- Open Access: Hybrid (optional OA)
- Field: Oncology
Special Notes
Lancet Oncology is part of the Lancet Group and shares its editorial philosophy of broad clinical and policy impact. Transfer system within Lancet family (The Lancet, Lancet Digital Health, eClinicalMedicine). Lancet-style unstructured summary followed by structured research-in-context panel. The journal values international multicenter studies and global oncology perspectives. AI studies may be redirected to Lancet Digital Health unless demonstrating direct oncology clinical impact.
AI Writing Disclosure Policy
- Requirement level: Required
- Permitted scope: Language editing only — Acknowledgments disclosure required (Lancet Group policy)
- Disclosure location: Acknowledgments section
- AI-generated images: Must be disclosed; fabrication/falsification policies apply
- Policy URL: https://www.thelancet.com/lanonc/information-for-authors
Related skills
FAQ
Does it report impact factor and APC?
No; it carries no cached IF or APC data. It returns scope fit and links, and users verify current metrics at the journal sites.
How does it rank journals?
A composite score weighting scope alignment 40%, study-type fit 25%, tier match 20%, OA match 10%, and special fit 5%.